{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:46:16Z","timestamp":1791751576096,"version":"4.3.4"},"reference-count":293,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["82460499"],"award-info":[{"award-number":["82460499"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Natural Science Foundation of Gansu Province","award":["26JRRA027"],"award-info":[{"award-number":["26JRRA027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10495-026-02450-8","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:57:53Z","timestamp":1790359073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The cGAS-STING pathway: mechanistic basis, dual biological functions and translational therapeutic advances"],"prefix":"10.1007","volume":"31","author":[{"given":"Minjue","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4120-2352","authenticated-orcid":false,"given":"Lizhou","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5312-1806","authenticated-orcid":false,"given":"Wangzheqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5498-6130","authenticated-orcid":false,"given":"Fei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"24","key":"2450_CR1","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1097\/CM9.0000000000003904","volume":"138","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Ma Y, Zhao J, Zhang X, Gan C, Gao J et al (2025) cGAS-STING signaling pathway as a therapeutic target in human diseases. Chin Med J (Engl) 138(24):3251\u20133284","journal-title":"Chin Med J (Engl)"},{"key":"2450_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1649046","volume":"16","author":"Y Ka","year":"2025","unstructured":"Ka Y, Tan T, Fan Y, Liu W, Wang A, Wang W et al (2025) STING pathways and Sj\u00f6gren\u2019s syndrome: exploration from mechanism to treatment. Front Immunol 16:1649046","journal-title":"Front Immunol"},{"issue":"8","key":"2450_CR3","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1021\/acs.jmedchem.9b01039","volume":"63","author":"H Zhang","year":"2020","unstructured":"Zhang H, You QD, Xu XL (2020) Targeting stimulator of interferon genes (STING): a medicinal chemistry perspective. J Med Chem 63(8):3785\u20133816","journal-title":"J Med Chem"},{"issue":"2","key":"2450_CR4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.chom.2016.01.010","volume":"19","author":"Z Ma","year":"2016","unstructured":"Ma Z, Damania B (2016) The cGAS-STING defense pathway and its counteraction by viruses. Cell Host Microbe 19(2):150\u2013158","journal-title":"Cell Host Microbe"},{"issue":"3","key":"2450_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11912-023-01361-0","volume":"25","author":"JB Hines","year":"2023","unstructured":"Hines JB, Kacew AJ, Sweis RF (2023) The development of STING agonists and emerging results as a cancer immunotherapy. Curr Oncol Rep 25(3):189\u2013199","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"2450_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41584-024-01184-8","volume":"21","author":"R Goldbach-Mansky","year":"2025","unstructured":"Goldbach-Mansky R, Alehashemi S, de Jesus AA (2025) Emerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus. Nat Rev Rheumatol 21(1):22\u201345","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"2450_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103155","volume":"21","author":"Y Hu","year":"2022","unstructured":"Hu Y, Chen B, Yang F, Su Y, Yang D, Yao Y et al (2022) Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: biologic function, mechanisms and clinical prospection. Autoimmun Rev 21(9):103155","journal-title":"Autoimmun Rev"},{"issue":"9","key":"2450_CR8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A (2021) The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol 21(9):548\u2013569","journal-title":"Nat Rev Immunol"},{"key":"2450_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2026.101387","author":"D Guo","year":"2026","unstructured":"Guo D, Guo Y, Zhu C, Liao Y, Lin Z, Zhang H et al (2026) Programmed cell death network in cancer drug resistance: a framework for therapeutic intervention. Drug Resist Updat. https:\/\/doi.org\/10.1016\/j.drup.2026.101387 \u00a0IF: 22.0 Q1 B1","journal-title":"Drug Resist Updat"},{"issue":"3","key":"2450_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41594-023-00933-9","volume":"30","author":"DJ Patel","year":"2023","unstructured":"Patel DJ, Yu Y, Xie W (2023) CGAMP-activated cGAS-STING signaling: its bacterial origins and evolutionary adaptation by metazoans. Nat Struct Mol Biol 30(3):245\u2013260","journal-title":"Nat Struct Mol Biol"},{"key":"2450_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110945","volume":"132","author":"K Liu","year":"2020","unstructured":"Liu K, Lan Y, Li X, Li M, Cui L, Luo H et al (2020) Development of small molecule inhibitors\/agonists targeting STING for disease. Biomed Pharmacother 132:110945","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"2450_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.molcel.2021.01.024","volume":"81","author":"W Zhou","year":"2021","unstructured":"Zhou W, Mohr L, Maciejowski J, Kranzusch PJ (2021) cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing. Mol Cell 81(4):739\u201355.e7","journal-title":"Mol Cell"},{"issue":"16","key":"2450_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.167976","volume":"435","author":"GL Boccaccio","year":"2023","unstructured":"Boccaccio GL, Thomas MG, Garc\u00eda CC (2023) Membraneless organelles and condensates orchestrate innate immunity against viruses. J Mol Biol 435(16):167976","journal-title":"J Mol Biol"},{"issue":"9","key":"2450_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41581-022-00589-6","volume":"18","author":"S Skopelja-Gardner","year":"2022","unstructured":"Skopelja-Gardner S, An J, Elkon KB (2022) Role of the cGAS-STING pathway in systemic and organ-specific diseases. Nat Rev Nephrol 18(9):558\u2013572","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2450_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06931-3","volume":"23","author":"S Nesci","year":"2025","unstructured":"Nesci S, Marchi S, Hu J, Marincola FM, Algieri C (2025) Inflammatory mitochondrial signalling and viral mimicry in cancer. J Transl Med 23(1):982","journal-title":"J Transl Med"},{"issue":"1","key":"2450_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-021-00554-y","volume":"6","author":"L Yu","year":"2021","unstructured":"Yu L, Liu P (2021) Cytosolic DNA sensing by cGAS: regulation, function, and human diseases. Signal Transduct Target Ther 6(1):170","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"2450_CR17","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.scib.2023.04.028","volume":"68","author":"J Gao","year":"2023","unstructured":"Gao J, Yang L, Lei S, Zhou F, Nie H, Peng B et al (2023) Stimuli-activatable PROTACs for precise protein degradation and cancer therapy. Sci Bull 68(10):1069\u20131085","journal-title":"Sci Bull"},{"issue":"17","key":"2450_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2022.167569","volume":"434","author":"R Nussinov","year":"2022","unstructured":"Nussinov R, Zhang M, Maloney R, Liu Y, Tsai CJ, Jang H (2022) Allostery: allosteric cancer drivers and innovative allosteric drugs. J Mol Biol 434(17):167569","journal-title":"J Mol Biol"},{"issue":"7748","key":"2450_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41586-019-0998-5","volume":"567","author":"G Shang","year":"2019","unstructured":"Shang G, Zhang C, Chen ZJ, Bai XC, Zhang X (2019) Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP-AMP. Nature 567(7748):389\u2013393","journal-title":"Nature"},{"issue":"11","key":"2450_CR20","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/s41590-025-02283-8","volume":"26","author":"BC Zhang","year":"2025","unstructured":"Zhang BC, Pedersen A, Reinert LS, Li Y, Narita R, Idorn M et al (2025) STING signals to NF-\u03baB from late endolysosomal compartments using IRF3 as an adaptor. Nat Immunol 26(11):1916\u20131930","journal-title":"Nat Immunol"},{"key":"2450_CR21","doi-asserted-by":"publisher","first-page":"112322","DOI":"10.1016\/j.cellsig.2025.112322","volume":"139","author":"Y Wang","year":"2026","unstructured":"Wang Y, Luo Y, Zhou F, Li D (2026) STING-driven activation of TFEB\/TFE3 establishes a negative feedback loop to control immune homeostasis. Cell Signal 139:112322","journal-title":"Cell Signal"},{"issue":"3","key":"2450_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41423-019-0205-5","volume":"16","author":"AL Hansen","year":"2019","unstructured":"Hansen AL, Mukai K, Schopfer FJ, Taguchi T, Holm CK (2019) STING palmitoylation as a therapeutic target. Cell Mol Immunol 16(3):236\u2013241","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"2450_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00204-025-04206-w","volume":"100","author":"Y Wang","year":"2026","unstructured":"Wang Y, Wu S, Zhang X, Zheng W, Wang Z, Zhang J et al (2026) cGAS-STING and autophagy: crosstalk, molecular mechanisms, and targeted therapy. Arch Toxicol 100(1):145\u2013172","journal-title":"Arch Toxicol"},{"key":"2450_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1557632","volume":"16","author":"T Rubin","year":"2025","unstructured":"Rubin T, Bernier S, Hoon Lim LS, Salman MS, Leung E, Mhanni A et al (2025) Two rare mutations in homozygosity synergize to silence TREX1 in Aicardi-Gouti\u00e8res syndrome. Front Immunol 16:1557632","journal-title":"Front Immunol"},{"issue":"6","key":"2450_CR25","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.celrep.2014.08.010","volume":"8","author":"P Gao","year":"2014","unstructured":"Gao P, Zillinger T, Wang W, Ascano M, Dai P, Hartmann G et al (2014) Binding-pocket and lid-region substitutions render human STING sensitive to the species-specific drug DMXAA. Cell Rep 8(6):1668\u20131676","journal-title":"Cell Rep"},{"issue":"10","key":"2450_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077846","volume":"8","author":"G Yi","year":"2013","unstructured":"Yi G, Brendel VP, Shu C, Li P, Palanathan S, Cheng Kao C (2013) Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides. PLoS ONE 8(10):e77846","journal-title":"PLoS ONE"},{"issue":"20","key":"2450_CR27","doi-asserted-by":"publisher","first-page":"6187","DOI":"10.1111\/febs.16137","volume":"289","author":"Z Hong","year":"2022","unstructured":"Hong Z, Ma T, Liu X, Wang C (2022) CGAS-STING pathway: post-translational modifications and functions in sterile inflammatory diseases. FEBS J 289(20):6187\u20136208","journal-title":"FEBS J"},{"key":"2450_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cells11193043","author":"Y Yu","year":"2022","unstructured":"Yu Y, Liu J, Liu C, Liu R, Liu L, Yu Z et al (2022) Post-translational modifications of cGAS-STING: a critical switch for immune regulation. Cells. https:\/\/doi.org\/10.3390\/cells11193043 \u00a0IF: 6.0 Q2 B2","journal-title":"Cells"},{"key":"2450_CR29","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.2147\/DDDT.S501773","volume":"19","author":"Y Chen","year":"2025","unstructured":"Chen Y, Yue S, Yu L, Cao J, Liu Y, Deng A et al (2025) Regulation and function of the cGAS-STING pathway: mechanisms, post-translational modifications, and therapeutic potential in immunotherapy. Drug Des Devel Ther 19:1721\u20131739","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"2450_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.immuni.2016.08.014","volume":"45","author":"MM Hu","year":"2016","unstructured":"Hu MM, Yang Q, Xie XQ, Liao CY, Lin H, Liu TT et al (2016) Sumoylation promotes the stability of the DNA sensor cGAS and the adaptor STING to regulate the kinetics of response to DNA virus. Immunity 45(3):555\u2013569","journal-title":"Immunity"},{"issue":"20","key":"2450_CR31","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1038\/s44318-024-00212-3","volume":"43","author":"J Xie","year":"2024","unstructured":"Xie J, Lu ZN, Bai SH, Cui XF, Lian HY, Xie CY et al (2024) Heterochromatin formation and remodeling by IRTKS condensates counteract cellular senescence. Embo J 43(20):4542\u20134577","journal-title":"Embo J"},{"key":"2450_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cytogfr.2022.09.003","volume":"68","author":"J Liu","year":"2022","unstructured":"Liu J, Rui K, Peng N, Luo H, Zhu B, Zuo X et al (2022) The cGAS-STING pathway: post-translational modifications and functional implications in diseases. Cytokine Growth Factor Rev 68:69\u201380","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"2450_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010233","volume":"18","author":"L Liang","year":"2022","unstructured":"Liang L, Shen Y, Hu Y, Liu H, Cao J (2022) cGAS exacerbates Schistosoma japonicum infection in a STING-type I IFN-dependent and independent manner. PLoS Pathog 18(2):e1010233","journal-title":"PLoS Pathog"},{"issue":"1","key":"2450_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1042\/BST20221296","volume":"52","author":"K Essandoh","year":"2024","unstructured":"Essandoh K, Teuber JP, Brody MJ (2024) Regulation of cardiomyocyte intracellular trafficking and signal transduction by protein palmitoylation. Biochem Soc Trans 52(1):41\u201353","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"2450_CR35","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00373-24","volume":"15","author":"C Dogrammatzis","year":"2024","unstructured":"Dogrammatzis C, Saud R, Waisner H, Lasnier S, Suma SM, Grieshaber B et al (2024) Tracing the STING exocytosis pathway during herpes viruses infection. MBio 15(4):e00373-24","journal-title":"MBio"},{"issue":"3","key":"2450_CR36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3350\/cmh.2024.0107","volume":"30","author":"Q Wang","year":"2024","unstructured":"Wang Q, Bu Q, Xu Z, Liang Y, Zhou J, Pan Y et al (2024) Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy. Clin Mol Hepatol 30(3):515\u2013538","journal-title":"Clin Mol Hepatol"},{"key":"2450_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217842","author":"Y Wu","year":"2020","unstructured":"Wu Y, Li S (2020) Role of post-translational modifications of cGAS in innate immunity. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21217842 \u00a0IF: 5.6 Q1 B3","journal-title":"Int J Mol Sci"},{"key":"2450_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1597443","volume":"16","author":"H Luo","year":"2025","unstructured":"Luo H, Tian T, Hu C, Hao F (2025) Targeting the cGAS-STING pathway: emerging strategies and challenges for the treatment of inflammatory skin diseases. Front Pharmacol 16:1597443","journal-title":"Front Pharmacol"},{"key":"2450_CR39","doi-asserted-by":"publisher","first-page":"105368","DOI":"10.1016\/j.critrevonc.2026.105368","volume":"224","author":"S Majaz","year":"2026","unstructured":"Majaz S, Ahmad A, Liu D, Ud-Din A, Khan I, Cui Y et al (2026) Context-dependent rewiring of the cGAS-STING pathway in cancer: implications for immunotherapy and therapeutic resistance. Crit Rev Oncol Hematol 224:105368","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"2450_CR40","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s00705-021-05211-x","volume":"166","author":"S Anwar","year":"2021","unstructured":"Anwar S, Ul Islam K, Azmi MI, Iqbal J (2021) cGAS-STING-mediated sensing pathways in DNA and RNA virus infections: crosstalk with other sensing pathways. Arch Virol 166(12):3255\u20133268","journal-title":"Arch Virol"},{"key":"2450_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1586806","volume":"16","author":"Z Chen","year":"2025","unstructured":"Chen Z, Zhao B (2025) The role of tumor-associated macrophages in HPV induced cervical cancer. Front Immunol 16:1586806","journal-title":"Front Immunol"},{"issue":"2","key":"2450_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/14728214.2025.2504376","volume":"30","author":"D Li","year":"2025","unstructured":"Li D, Rudloff U (2025) Emerging therapeutics targeting tumor-associated macrophages for the treatment of solid organ cancers. Expert Opin Emerg Drugs 30(2):109\u2013147","journal-title":"Expert Opin Emerg Drugs"},{"issue":"9","key":"2450_CR43","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1039\/D4BM01532K","volume":"13","author":"G Fu","year":"2025","unstructured":"Fu G, Zhao Y, Mao C, Liu Y (2025) Enhancing nano-immunotherapy of cancer through cGAS-STING pathway modulation. Biomater Sci 13(9):2235\u20132260","journal-title":"Biomater Sci"},{"key":"2450_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.996663","volume":"13","author":"Z Tian","year":"2022","unstructured":"Tian Z, Zeng Y, Peng Y, Liu J, Wu F (2022) Cancer immunotherapy strategies that target the cGAS-STING pathway. Front Immunol 13:996663","journal-title":"Front Immunol"},{"key":"2450_CR45","doi-asserted-by":"publisher","first-page":"445","DOI":"10.18632\/oncotarget.28740","volume":"16","author":"H Qian","year":"2025","unstructured":"Qian H, Ali H, Karri V, Low JT, Ashley DM, Heimberger AB et al (2025) Beyond DNA damage response: immunomodulatory attributes of CHEK2 in solid tumors. Oncotarget 16:445\u2013453","journal-title":"Oncotarget"},{"issue":"3","key":"2450_CR46","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.tips.2025.01.006","volume":"46","author":"Y Song","year":"2025","unstructured":"Song Y, Yu B (2025) Leveraging non-enzymatic functions of LSD1 for novel therapeutics. Trends Pharmacol Sci 46(3):204\u2013219","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"2450_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/iub.70009","volume":"77","author":"Y Li","year":"2025","unstructured":"Li Y, Jiang X, Cao H, Wu X, Zhang H, Ma H et al (2025) The cGAS-STING-related signature affects the prognosis of colorectal cancer through its regulation of multiple immune cells. IUBMB Life 77(3):e70009","journal-title":"IUBMB Life"},{"key":"2450_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2022.102170","volume":"69","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Chen C, Xia B, Xu P (2022) Chemical regulation of the cGAS-STING pathway. Curr Opin Chem Biol 69:102170","journal-title":"Curr Opin Chem Biol"},{"key":"2450_CR49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163452","author":"JT Low","year":"2024","unstructured":"Low JT, Brown MC, Reitman ZJ, Bernstock JD, Markert JM, Friedman GK et al (2024) Understanding and therapeutically exploiting cGAS\/STING signaling in glioblastoma. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI163452 \u00a0IF: 14.3 Q1 B1","journal-title":"J Clin Invest"},{"key":"2450_CR50","doi-asserted-by":"publisher","first-page":"116803","DOI":"10.1016\/j.bcp.2025.116803","volume":"234","author":"S Wang","year":"2025","unstructured":"Wang S, Huang J, Zeng T, Chen Y, Xu Y, Zhang B (2025) Parps in immune response: potential targets for cancer immunotherapy. Biochem Pharmacol 234:116803","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"2450_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00005-017-0481-7","volume":"66","author":"O Sokolowska","year":"2018","unstructured":"Sokolowska O, Nowis D (2018) STING signaling in cancer cells: Important or not? Arch Immunol Ther Exp (Warsz) 66(2):125\u2013132","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"1","key":"2450_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.immuni.2020.06.009","volume":"53","author":"J Wu","year":"2020","unstructured":"Wu J, Dobbs N, Yang K, Yan N (2020) Interferon-independent activities of mammalian STING mediate antiviral response and tumor immune evasion. Immunity 53(1):115\u201326.e5","journal-title":"Immunity"},{"key":"2450_CR53","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2147\/OTT.S298958","volume":"14","author":"F Pu","year":"2021","unstructured":"Pu F, Chen F, Liu J, Zhang Z, Shao Z (2021) Immune regulation of the cGAS-STING signaling pathway in the tumor microenvironment and its clinical application. Onco Targets Ther 14:1501\u20131516","journal-title":"Onco Targets Ther"},{"issue":"11","key":"2450_CR54","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1038\/s41418-019-0302-0","volume":"26","author":"CX Zhang","year":"2019","unstructured":"Zhang CX, Ye SB, Ni JJ, Cai TT, Liu YN, Huang DJ et al (2019) STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion. Cell Death Differ 26(11):2314\u20132328","journal-title":"Cell Death Differ"},{"key":"2450_CR55","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.149346","author":"M Anastasiou","year":"2021","unstructured":"Anastasiou M, Newton GA, Kaur K, Carrillo-Salinas FJ, Smolgovsky SA, Bayer AL et al (2021) Endothelial STING controls T cell transmigration in an IFNI-dependent manner. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.149346 \u00a0IF: 6.8 Q1 B1","journal-title":"JCI Insight"},{"issue":"25","key":"2450_CR56","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.7150\/thno.37574","volume":"9","author":"T Su","year":"2019","unstructured":"Su T, Zhang Y, Valerie K, Wang XY, Lin S, Zhu G (2019) STING activation in cancer immunotherapy. Theranostics 9(25):7759\u20137771","journal-title":"Theranostics"},{"issue":"10","key":"2450_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.714","volume":"5","author":"R Wang","year":"2020","unstructured":"Wang R, Lan C, Benlagha K, Camara NOS, Miller H, Kubo M et al (2020) The interaction of innate immune and adaptive immune system. MedComm 5(10):e714","journal-title":"MedComm"},{"key":"2450_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27144638","author":"K Luo","year":"2022","unstructured":"Luo K, Li N, Ye W, Gao H, Luo X, Cheng B (2022) Activation of stimulation of interferon genes (STING) signal and cancer immunotherapy. Molecules. https:\/\/doi.org\/10.3390\/molecules27144638 \u00a0IF: 5.1 Q2 B3","journal-title":"Molecules"},{"issue":"12","key":"2450_CR59","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1016\/j.apsb.2020.03.001","volume":"10","author":"C Ding","year":"2020","unstructured":"Ding C, Song Z, Shen A, Chen T, Zhang A (2020) Small molecules targeting the innate immune cGAS\u2012STING\u2012TBK1 signaling pathway. Acta Pharm Sin B 10(12):2272\u20132298","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"2450_CR60","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1158\/2159-8290.CD-23-0700","volume":"14","author":"T Tani","year":"2024","unstructured":"Tani T, Mathsyaraja H, Campisi M, Li ZH, Haratani K, Fahey CG et al (2024) TREX1 inactivation unleashes cancer cell STING-interferon signaling and promotes antitumor immunity. Cancer Discov 14(5):752\u2013765","journal-title":"Cancer Discov"},{"issue":"12","key":"2450_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0339375","volume":"20","author":"M Li","year":"2025","unstructured":"Li M, Zhao Y, Zhao L, Chen X, Kang J, Tong A et al (2025) The combination of LILRB4-targeting NK cell engagers and cGAS-STING agonists enhances the anti-multiple myeloma immune activity of NK cells. PLoS ONE 20(12):e0339375","journal-title":"PLoS ONE"},{"key":"2450_CR62","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/bs.ircmb.2019.06.001","volume":"348","author":"J Sprooten","year":"2019","unstructured":"Sprooten J, Agostinis P, Garg AD (2019) Type I interferons and dendritic cells in cancer immunotherapy. Int Rev Cell Mol Biol 348:217\u2013262","journal-title":"Int Rev Cell Mol Biol"},{"key":"2450_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1739154","volume":"16","author":"K Zhang","year":"2025","unstructured":"Zhang K, Liu J, Liu Q, Zhu N, Ye B (2025) Macrophage-derived chemokines in T cell regulation: implications for cancer immunotherapy. Front Immunol 16:1739154","journal-title":"Front Immunol"},{"key":"2450_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-026-09756-4","author":"M Gadelkarim","year":"2026","unstructured":"Gadelkarim M, Elsayed A, Nazir A, Elsayed Y, Habashneh A, Iqbal O et al (2026) The Fas-FasL system: from apoptosis regulator to therapeutic target in autoimmunity, cancer, and transplantation. Immunol Res. https:\/\/doi.org\/10.1007\/s12026-026-09756-4 \u00a0IF: 2.7 Q3 B4","journal-title":"Immunol Res"},{"key":"2450_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127605","volume":"62","author":"H Wei","year":"2025","unstructured":"Wei H, Wang Y, Jiang S, Zhang X, Zhang J (2025) The roles of tissue-resident memory T cells (TRMs) in diseases and vaccine development: a comprehensive review. Vaccine 62:127605","journal-title":"Vaccine"},{"key":"2450_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2025.110612","volume":"282","author":"JD Zambrano-Romero","year":"2026","unstructured":"Zambrano-Romero JD, R\u00edos-Ram\u00edrez DB, Garc\u00eda-Rasilla VY, Ruiz-Medina BE, Licona-Lim\u00f3n P (2026) TGF-\u03b2: a silent player regulating CD8 T cell memory. Clin Immunol 282:110612","journal-title":"Clin Immunol"},{"issue":"83","key":"2450_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add1153","volume":"8","author":"L Wang-Bishop","year":"2023","unstructured":"Wang-Bishop L, Kimmel BR, Ngwa VM, Madden MZ, Baljon JJ, Florian DC et al (2023) STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy. Sci Immunol 8(83):eadd1153","journal-title":"Sci Immunol"},{"key":"2450_CR68","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001906","author":"M Chelvanambi","year":"2021","unstructured":"Chelvanambi M, Fecek RJ, Taylor JL, Storkus WJ (2021) STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-001906 \u00a0IF: 11.7 Q1 B1","journal-title":"J Immunother Cancer"},{"key":"2450_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102458","author":"R Reschke","year":"2022","unstructured":"Reschke R, Olson DJ (2022) Leveraging STING, Batf3 dendritic cells, CXCR3 ligands, and other components related to innate immunity to induce a \u201chot\u201d tumor microenvironment that is responsive to immunotherapy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14102458 \u00a0IF: 4.8 Q2 B3","journal-title":"Cancers (Basel)"},{"issue":"2","key":"2450_CR70","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/neuonc\/noad185","volume":"26","author":"A Saijo","year":"2024","unstructured":"Saijo A, Ogino H, Butowski NA, Tedesco MR, Gibson D, Watchmaker PB et al (2024) A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas. Neuro Oncol 26(2):335\u2013347","journal-title":"Neuro Oncol"},{"issue":"1","key":"2450_CR71","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1777624","volume":"9","author":"J Le Naour","year":"2020","unstructured":"Le Naour J, Zitvogel L, Galluzzi L, Vacchelli E, Kroemer G (2020) Trial watch: STING agonists in cancer therapy. Oncoimmunology 9(1):1777624","journal-title":"Oncoimmunology"},{"key":"2450_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9103323","author":"L Motedayen Aval","year":"2020","unstructured":"Motedayen Aval L, Pease JE, Sharma R, Pinato DJ (2020) Challenges and opportunities in the clinical development of STING agonists for cancer immunotherapy. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9103323 \u00a0IF: 3.3 Q1 B3","journal-title":"J Clin Med"},{"key":"2450_CR73","first-page":"1096","volume":"9","author":"B Tang","year":"2026","unstructured":"Tang B, Guo D, Hou W, Zhang W, Zhang W, Ma J et al (2026) Transarterial chemoembolization modulates the exosomal miR-32-5p\/cGAS-STING axis mediated macrophage ferroptosis, triggers immune remodeling, and enhances Anti-PD-1\/L1 efficacy in HCC. Research (Wash D C) 9:1096","journal-title":"Research (Wash D C)"},{"issue":"10","key":"2450_CR74","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11926-017-0689-x","volume":"19","author":"C Fiehn","year":"2017","unstructured":"Fiehn C (2017) Familial chilblain lupus - What can we learn from type I interferonopathies? Curr Rheumatol Rep 19(10):61","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"2450_CR75","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1189\/jlb.3MR0316-115R","volume":"101","author":"S Pawaria","year":"2017","unstructured":"Pawaria S, Sharma S, Baum R, N\u00fcndel K, Busto P, Gravallese EM et al (2017) Taking the STING out of TLR-driven autoimmune diseases: Good, bad, or indifferent? J Leukoc Biol 101(1):121\u2013126","journal-title":"J Leukoc Biol"},{"issue":"3","key":"2450_CR76","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.immuni.2022.01.011","volume":"55","author":"F Fueyo-Gonz\u00e1lez","year":"2022","unstructured":"Fueyo-Gonz\u00e1lez F, McGinty M, Ningoo M, Anderson L, Cantarelli C, Andrea A et al (2022) Interferon-\u03b2 acts directly on T cells to prolong allograft survival by enhancing regulatory T cell induction through Foxp3 acetylation. Immunity 55(3):459\u201374.e7","journal-title":"Immunity"},{"key":"2450_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.156009","volume":"158","author":"N Nishiyama","year":"2022","unstructured":"Nishiyama N, Nakahashi-Oda C, Shibuya A (2022) Interferon-\u03b2 promotes the survival and function of induced regulatory T cells. Cytokine 158:156009","journal-title":"Cytokine"},{"issue":"1-2","key":"2450_CR78","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jneuroim.2011.10.014","volume":"242","author":"M Chen","year":"2012","unstructured":"Chen M, Chen G, Deng S, Liu X, Hutton GJ, Hong J (2012) IFN-\u03b2 induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis. J Neuroimmunol 242(1\u20132):39\u201346","journal-title":"J Neuroimmunol"},{"key":"2450_CR79","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjac005","author":"Z Hong","year":"2022","unstructured":"Hong Z, Mei J, Guo H, Zhu J, Wang C (2022) Intervention of cGAS\u2012STING signaling in sterile inflammatory diseases. J Mol Cell Biol. https:\/\/doi.org\/10.1093\/jmcb\/mjac005 \u00a0IF: 6.0 Q2 B2","journal-title":"J Mol Cell Biol"},{"issue":"38","key":"2450_CR80","doi-asserted-by":"publisher","first-page":"e00942","DOI":"10.1002\/advs.202500942","volume":"12","author":"TX Zhang","year":"2025","unstructured":"Zhang TX, Yang X, Gao X, Du X, Lian X, Shao N et al (2025) Type I interferon signaling augments autoimmunity in neuromyelitis optica spectrum disorder. Adv Sci (Weinh) 12(38):e00942","journal-title":"Adv Sci (Weinh)"},{"issue":"35","key":"2450_CR81","doi-asserted-by":"publisher","first-page":"e04474","DOI":"10.1002\/advs.202504474","volume":"13","author":"A Nguyen","year":"2026","unstructured":"Nguyen A, Walsh SR, Deng L, Chen L, Wan Y (2026) Pre-encoded IFN-I sensitivity exacerbates memory T cell senescence in solid tumors. Adv Sci (Weinh) 13(35):e04474","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2450_CR82","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1038\/s41467-018-06890-y","volume":"9","author":"Y Liang","year":"2018","unstructured":"Liang Y, Tang H, Guo J, Qiu X, Yang Z, Ren Z et al (2018) Targeting IFN\u03b1 to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance. Nat Commun 9(1):4586","journal-title":"Nat Commun"},{"key":"2450_CR83","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13075-016-0946-9","volume":"18","author":"TD de Jong","year":"2016","unstructured":"de Jong TD, Vosslamber S, Mantel E, de Ridder S, Wesseling JG, van der Pouw Kraan TC et al (2016) Physiological evidence for diversification of IFN\u03b1- and IFN\u03b2-mediated response programs in different autoimmune diseases. Arthritis Res Ther 18:49","journal-title":"Arthritis Res Ther"},{"key":"2450_CR84","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ebiom.2019.09.059","volume":"49","author":"X Feng","year":"2019","unstructured":"Feng X, Bao R, Li L, Deisenhammer F, Arnason BGW, Reder AT (2019) Interferon-\u03b2 corrects massive gene dysregulation in multiple sclerosis: short-term and long-term effects on immune regulation and neuroprotection. EBioMedicine 49:269\u2013283","journal-title":"EBioMedicine"},{"issue":"11","key":"2450_CR85","doi-asserted-by":"publisher","first-page":"6705","DOI":"10.4049\/jimmunol.178.11.6705","volume":"178","author":"EY Chang","year":"2007","unstructured":"Chang EY, Guo B, Doyle SE, Cheng G (2007) Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J Immunol 178(11):6705\u20136709","journal-title":"J Immunol"},{"key":"2450_CR86","doi-asserted-by":"publisher","DOI":"10.1042\/EBC20253006","author":"B Yue","year":"2025","unstructured":"Yue B, Gao W, Lovell JF, Jin H, Huang J (2025) The cGAS-STING pathway in cancer immunity: dual roles, therapeutic strategies, and clinical challenges. Essays Biochem. https:\/\/doi.org\/10.1042\/EBC20253006 \u00a0IF: 5.7 Q1 B2","journal-title":"Essays Biochem"},{"issue":"4","key":"2450_CR87","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.immuni.2025.03.005","volume":"58","author":"P Lai","year":"2025","unstructured":"Lai P, Liu L, Bancaro N, Troiani M, Cal\u00ec B, Li Y et al (2025) Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven immunosuppression through the cGAS-STING pathway. Immunity 58(4):811\u201325.e7","journal-title":"Immunity"},{"issue":"2","key":"2450_CR88","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.mt.6300024","volume":"15","author":"SE Hensley","year":"2007","unstructured":"Hensley SE, Cun AS, Giles-Davis W, Li Y, Xiang Z, Lasaro MO et al (2007) Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector. Mol Ther 15(2):393\u2013403","journal-title":"Mol Ther"},{"key":"2450_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.905109","volume":"13","author":"H Wobma","year":"2022","unstructured":"Wobma H, Shin DS, Chou J, Dedeo\u011flu F (2022) Dysregulation of the cGAS-STING pathway in monogenic autoinflammation and lupus. Front Immunol 13:905109","journal-title":"Front Immunol"},{"issue":"2","key":"2450_CR90","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cyto.2015.02.012","volume":"74","author":"F Moghaddas","year":"2015","unstructured":"Moghaddas F, Masters SL (2015) Monogenic autoinflammatory diseases: cytokinopathies. Cytokine 74(2):237\u2013246","journal-title":"Cytokine"},{"key":"2450_CR91","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6687096","volume":"2021","author":"S Ling","year":"2021","unstructured":"Ling S, Xu JW (2021) Netosis as a pathogenic factor for heart failure. Oxid Med Cell Longev 2021:6687096","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"2450_CR92","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.it.2023.01.006","volume":"44","author":"H Xian","year":"2023","unstructured":"Xian H, Karin M (2023) Oxidized mitochondrial DNA: a protective signal gone awry. Trends Immunol 44(3):188\u2013200","journal-title":"Trends Immunol"},{"issue":"6","key":"2450_CR93","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.4049\/jimmunol.1600722","volume":"197","author":"K Peschke","year":"2016","unstructured":"Peschke K, Achleitner M, Frenzel K, Gerbaulet A, Ada SR, Zeller N et al (2016) Loss of Trex1 in dendritic cells is sufficient to trigger systemic autoimmunity. J Immunol 197(6):2157\u20132166","journal-title":"J Immunol"},{"key":"2450_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111550","volume":"128","author":"W Luo","year":"2024","unstructured":"Luo W, Song Z, Xu G, Wang H, Mu W, Wen J et al (2024) LicochalconeB inhibits cGAS-STING signaling pathway and prevents autoimmunity diseases. Int Immunopharmacol 128:111550","journal-title":"Int Immunopharmacol"},{"key":"2450_CR95","first-page":"1026","volume":"8","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Shi F, Hao H, Wang Z, Li J, Liu B et al (2025) Hypertension increases susceptibility to lead-induced microglial polarization via ANT1-mediated mitochondrial DNA\/cGAS\/STING signaling. Research (Wash D C) 8:1026","journal-title":"Research (Wash D C)"},{"key":"2450_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114480","volume":"238","author":"J Zhao","year":"2022","unstructured":"Zhao J, Xiao R, Zeng R, He E, Zhang A (2022) Small molecules targeting cGAS-STING pathway for autoimmune disease. Eur J Med Chem 238:114480","journal-title":"Eur J Med Chem"},{"key":"2450_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29133121","author":"X Yu","year":"2024","unstructured":"Yu X, Cai L, Yao J, Li C, Wang X (2024) Agonists and inhibitors of the cGAS-STING pathway. Molecules. https:\/\/doi.org\/10.3390\/molecules29133121 \u00a0IF: 5.1 Q2 B3","journal-title":"Molecules"},{"key":"2450_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28073127","author":"S Zhang","year":"2023","unstructured":"Zhang S, Zheng R, Pan Y, Sun H (2023) Potential therapeutic value of the STING inhibitors. Molecules. https:\/\/doi.org\/10.3390\/molecules28073127 \u00a0IF: 5.1 Q2 B3","journal-title":"Molecules"},{"issue":"11","key":"2450_CR99","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1080\/13543776.2022.2144220","volume":"32","author":"A Shen","year":"2022","unstructured":"Shen A, Chen M, Chen Q, Liu Z, Zhang A (2022) Recent advances in the development of STING inhibitors: an updated patent review. Expert Opin Ther Pat 32(11):1131\u20131143","journal-title":"Expert Opin Ther Pat"},{"issue":"3","key":"2450_CR100","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/med.21649","volume":"40","author":"JJ Wu","year":"2020","unstructured":"Wu JJ, Zhao L, Hu HG, Li WH, Li YM (2020) Agonists and inhibitors of the STING pathway: potential agents for immunotherapy. Med Res Rev 40(3):1117\u20131141","journal-title":"Med Res Rev"},{"key":"2450_CR101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.954129","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, Zou Y, Zhou X, Zhou J (2022) Inhibitory targeting cGAS-STING-TBK1 axis: emerging strategies for autoimmune diseases therapy. Front Immunol 13:954129","journal-title":"Front Immunol"},{"key":"2450_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117632","volume":"291","author":"K Wu","year":"2025","unstructured":"Wu K, Xu Y, Liu P, Chen K, Zhao Y (2025) STING inhibitors and degraders: potential therapeutic agents in inflammatory diseases. Eur J Med Chem 291:117632","journal-title":"Eur J Med Chem"},{"key":"2450_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114791","volume":"244","author":"X Tian","year":"2022","unstructured":"Tian X, Xu F, Zhu Q, Feng Z, Dai W, Zhou Y et al (2022) Medicinal chemistry perspective on cGAS-STING signaling pathway with small molecule inhibitors. Eur J Med Chem 244:114791","journal-title":"Eur J Med Chem"},{"issue":"11","key":"2450_CR104","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/j.scib.2024.03.056","volume":"69","author":"C Zhang","year":"2024","unstructured":"Zhang C, Liu Y, Li G, Yang Z, Han C, Sun X et al (2024) Targeting the undruggables-the power of protein degraders. Sci Bull 69(11):1776\u20131797","journal-title":"Sci Bull"},{"key":"2450_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1631132","volume":"16","author":"W Jiang","year":"2025","unstructured":"Jiang W, Yang X, Liu H, Wang C, Niu H, Yu W (2025) STING-targeting PROTACs: emerging therapeutic tools for enhanced immunotherapy in inflammatory diseases. Front Immunol 16:1631132","journal-title":"Front Immunol"},{"key":"2450_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13040371","author":"Y Shen","year":"2025","unstructured":"Shen Y, Huang W, Nie J, Zhang L (2025) Progress update on STING agonists as vaccine adjuvants. Vaccines. https:\/\/doi.org\/10.3390\/vaccines13040371 \u00a0IF: 3.5 Q2 B3","journal-title":"Vaccines"},{"issue":"14","key":"2450_CR107","doi-asserted-by":"publisher","first-page":"e2417686","DOI":"10.1002\/advs.202417686","volume":"12","author":"W Mu","year":"2025","unstructured":"Mu W, Xu G, Li L, Wen J, Xiu Y, Zhao J et al (2025) Carnosic acid directly targets STING C-terminal tail to improve STING-mediated inflammatory diseases. Adv Sci (Weinh) 12(14):e2417686","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"2450_CR108","first-page":"402","volume":"22","author":"Y Xiu","year":"2024","unstructured":"Xiu Y, Wang S, Zhang P, Li C, Wu Z, Wen J et al (2024) Total glucosides of paeony alleviates cGAS-STING-mediated diseases by blocking the STING-IRF3 interaction. Chin J Nat Med 22(5):402\u2013415","journal-title":"Chin J Nat Med"},{"key":"2450_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155404","volume":"128","author":"W Shi","year":"2024","unstructured":"Shi W, Xu G, Gao Y, Yang H, Liu T, Zhao J et al (2024) Compound Danshen Dripping Pill effectively alleviates cGAS-STING-triggered diseases by disrupting STING-TBK1 interaction. Phytomedicine 128:155404","journal-title":"Phytomedicine"},{"key":"2450_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103314","volume":"66","author":"T Prabakaran","year":"2021","unstructured":"Prabakaran T, Troldborg A, Kumpunya S, Alee I, Marinkovi\u0107 E, Windross SJ et al (2021) A STING antagonist modulating the interaction with STIM1 blocks ER-to-Golgi trafficking and inhibits lupus pathology. EBioMedicine 66:103314","journal-title":"EBioMedicine"},{"key":"2450_CR111","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/JIR.S277716","volume":"14","author":"B Mdkhana","year":"2021","unstructured":"Mdkhana B, Saheb Sharif-Askari N, Ramakrishnan RK, Goel S, Hamid Q, Halwani R (2021) Nucleic acid-sensing pathways during SARS-CoV-2 infection: expectations versus reality. J Inflamm Res 14:199\u2013216","journal-title":"J Inflamm Res"},{"key":"2450_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114838","volume":"244","author":"D Li","year":"2001","unstructured":"Li D, Yu D, Li Y, Yang R (2001) A bibliometric analysis of PROTAC from 2001 to 2021. Eur J Med Chem 244:114838","journal-title":"Eur J Med Chem"},{"issue":"3","key":"2450_CR113","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s M, Langley DR, Crews CM (2022) PROTAC targeted protein degraders: the past is prologue. Nat Rev Drug Discov 21(3):181\u2013200","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2450_CR114","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","volume":"7","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhao J, Zhong K, Tong A, Jia D (2022) Targeted protein degradation: mechanisms, strategies and application. Signal Transduct Target Ther 7(1):113","journal-title":"Signal Transduct Target Ther"},{"key":"2450_CR115","doi-asserted-by":"publisher","first-page":"115193","DOI":"10.1016\/j.addr.2024.115193","volume":"207","author":"MZ Liao","year":"2024","unstructured":"Liao MZ, Lu D, Lu T, Gibiansky L, Deng R, Samineni D et al (2024) Clinical pharmacology strategies to accelerate the development of polatuzumab vedotin and summary of key findings. Adv Drug Deliv Rev 207:115193","journal-title":"Adv Drug Deliv Rev"},{"key":"2450_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108437","volume":"160","author":"C Zhou","year":"2025","unstructured":"Zhou C, Yang S, Wang J, Pan W, Yao H, Li G et al (2025) Recent advances in PROTAC-based antiviral and antibacterial therapeutics. Bioorg Chem 160:108437","journal-title":"Bioorg Chem"},{"key":"2450_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114290","volume":"235","author":"C Wang","year":"2022","unstructured":"Wang C, Zheng C, Wang H, Zhang L, Liu Z, Xu P (2022) The state of the art of PROTAC technologies for drug discovery. Eur J Med Chem 235:114290","journal-title":"Eur J Med Chem"},{"key":"2450_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117584","volume":"180","author":"SH Zhang","year":"2024","unstructured":"Zhang SH, Zeng N, Xu JZ, Liu CQ, Xu MY, Sun JX et al (2024) Recent breakthroughs in innovative elements, multidimensional enhancements, derived technologies, and novel applications of PROTACs. Biomed Pharmacother 180:117584","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2450_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02804-y","volume":"20","author":"X Zhu","year":"2023","unstructured":"Zhu X, Liu W, Tang X, Chen Y, Ge X, Ke Q et al (2023) The BET PROTAC inhibitor dBET6 protects against retinal degeneration and inhibits the cGAS-STING in response to light damage. J Neuroinflammation 20(1):119","journal-title":"J Neuroinflammation"},{"key":"2450_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010079","author":"J Kabiljo","year":"2019","unstructured":"Kabiljo J, Harpain F, Carotta S, Bergmann M (2019) Radiotherapy as a backbone for novel concepts in cancer immunotherapy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12010079 \u00a0IF: 4.8 Q2 B3","journal-title":"Cancers (Basel)"},{"key":"2450_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117096","volume":"240","author":"X Lin","year":"2025","unstructured":"Lin X, Ma L, Huang J, Cai Y, Gu X, Chen Y et al (2025) Midazolam negatively regulates STING trafficking and activation and protects against Listeria monocytogenes infection in vivo. Biochem Pharmacol 240:117096","journal-title":"Biochem Pharmacol"},{"key":"2450_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225603","author":"S Sato","year":"2021","unstructured":"Sato S, Sawada Y, Nakamura M (2021) STING signaling and skin cancers. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13225603 \u00a0IF: 4.8 Q2 B3","journal-title":"Cancers (Basel)"},{"key":"2450_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17111882","author":"M Magoola","year":"2025","unstructured":"Magoola M, Niazi SK (2025) Current progress and future perspectives of RNA-based cancer vaccines: a 2025 update. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers17111882 \u00a0IF: 4.8 Q2 B3","journal-title":"Cancers (Basel)"},{"key":"2450_CR124","doi-asserted-by":"publisher","first-page":"107137","DOI":"10.1016\/j.ejps.2025.107137","volume":"211","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang W, Zhang Y, Gao P, Fleishman JS, Wang H (2025) cGAS-STING targeting offers a novel therapeutic paradigm in cardiovascular diseases. Eur J Pharm Sci 211:107137","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"2450_CR125","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.path.2023.04.006","volume":"16","author":"PH Parrack","year":"2023","unstructured":"Parrack PH, Zucker SD, Zhao L (2023) Liver pathology related to onco-therapeutic agents. Surg Pathol Clin 16(3):499\u2013518","journal-title":"Surg Pathol Clin"},{"issue":"8","key":"2450_CR126","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1021\/acsabm.3c01305","volume":"7","author":"LE Pastora","year":"2024","unstructured":"Pastora LE, Namburu NS, Arora K, Christov PP, Wilson JT (2024) STING-pathway inhibiting nanoparticles (SPINs) as a platform for treatment of inflammatory diseases. ACS Appl Bio Mater 7(8):4867\u20134878","journal-title":"ACS Appl Bio Mater"},{"issue":"1","key":"2450_CR127","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12951-025-03389-9","volume":"23","author":"Y Su","year":"2025","unstructured":"Su Y, Chen R, Wang B, Wang T, Tao J, Diao Q et al (2025) Erythrocyte membrane camouflaged celastrol and bilirubin self-assembly for rheumatoid arthritis immunotherapy based on STING inhibition and RONS clearance. J Nanobiotechnology 23(1):318","journal-title":"J Nanobiotechnology"},{"issue":"4","key":"2450_CR128","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40257-023-00774-8","volume":"24","author":"D Niebel","year":"2023","unstructured":"Niebel D, de Vos L, Fetter T, Br\u00e4gelmann C, Wenzel J (2023) Cutaneous lupus erythematosus: an update on pathogenesis and future therapeutic directions. Am J Clin Dermatol 24(4):521\u2013540","journal-title":"Am J Clin Dermatol"},{"key":"2450_CR129","first-page":"207","volume":"47","author":"R Lu","year":"2024","unstructured":"Lu R, Qu Y, Wang Z, He Z, Xu S, Cheng P et al (2024) TBK1 pharmacological inhibition mitigates osteoarthritis through attenuating inflammation and cellular senescence in chondrocytes. J Orthop Transl 47:207\u2013222","journal-title":"J Orthop Transl"},{"key":"2450_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108658","volume":"107","author":"S Hu","year":"2022","unstructured":"Hu S, Gao Y, Gao R, Wang Y, Qu Y, Yang J et al (2022) The selective STING inhibitor H-151 preserves myocardial function and ameliorates cardiac fibrosis in murine myocardial infarction. Int Immunopharmacol 107:108658","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"2450_CR131","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.65.8.16","volume":"65","author":"M Tanaka","year":"2024","unstructured":"Tanaka M, Yasuda H, Nakamura S, Shimazawa M (2024) H-151, a selective STING inhibitor, has potential as a treatment for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 65(8):16","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"26","key":"2450_CR132","doi-asserted-by":"publisher","first-page":"e2302575","DOI":"10.1002\/advs.202302575","volume":"10","author":"F Cheng","year":"2023","unstructured":"Cheng F, Su T, Liu Y, Zhou S, Qi J, Guo W et al (2023) Targeting lymph nodes for systemic immunosuppression using cell-free-DNA-scavenging And cGAS-inhibiting nanomedicine-in-hydrogel for rheumatoid arthritis immunotherapy. Adv Sci (Weinh) 10(26):e2302575","journal-title":"Adv Sci (Weinh)"},{"issue":"24","key":"2450_CR133","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.2174\/0929867324666170911162331","volume":"25","author":"E Piscianz","year":"2018","unstructured":"Piscianz E, Cuzzoni E, Sharma R, Tesser A, Sapra P, Tommasini A (2018) Reappraisal of antimalarials in interferonopathies: new perspectives for old drugs. Curr Med Chem 25(24):2797\u20132810","journal-title":"Curr Med Chem"},{"key":"2450_CR134","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004762","author":"F Ju","year":"2022","unstructured":"Ju F, Luo Y, Lin C, Jia X, Xu Z, Tian R et al (2022) Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2022-004762 \u00a0IF: 11.7 Q1 B1","journal-title":"J Immunother Cancer"},{"key":"2450_CR135","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev-micro-091313-103409","volume":"68","author":"MH Orzalli","year":"2014","unstructured":"Orzalli MH, Knipe DM (2014) Cellular sensing of viral DNA and viral evasion mechanisms. Annu Rev Microbiol 68:477\u2013492","journal-title":"Annu Rev Microbiol"},{"key":"2450_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/v16040574","author":"MF Mart\u00ednez-L\u00f3pez","year":"2024","unstructured":"Mart\u00ednez-L\u00f3pez MF, Muslin C, Kyriakidis NC (2024) STINGing defenses: unmasking the mechanisms of DNA oncovirus-mediated immune escape. Viruses. https:\/\/doi.org\/10.3390\/v16040574 \u00a0IF: 3.8 Q2 B3","journal-title":"Viruses"},{"issue":"1","key":"2450_CR137","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02443-2","volume":"24","author":"C Yang","year":"2025","unstructured":"Yang C, Li S, Wang L (2025) Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics. Mol Cancer 24(1):225","journal-title":"Mol Cancer"},{"key":"2450_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13092160","author":"D Bartusik-Aebisher","year":"2025","unstructured":"Bartusik-Aebisher D, Rog\u00f3\u017c K, Aebisher D (2025) STING-activating nanoparticles combined with PD-1\/PD-L1 blockade: a synergistic approach in cancer immunotherapy. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13092160 \u00a0IF: 4.5 Q2 B3","journal-title":"Biomedicines"},{"key":"2450_CR139","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00099-20","author":"H Zhu","year":"2020","unstructured":"Zhu H, Zheng C (2020) The race between host antiviral innate immunity and the immune evasion strategies of Herpes Simplex Virus 1. Microbiol Mol Biol Rev. https:\/\/doi.org\/10.1128\/MMBR.00099-20IF: 11.8 Q1 B2","journal-title":"Microbiol Mol Biol Rev"},{"issue":"6","key":"2450_CR140","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s12250-016-3877-3","volume":"31","author":"H Gao","year":"2016","unstructured":"Gao H, Song Y, Liu C, Liang Q (2016) KSHV strategies for host dsDNA sensing machinery. Virol Sin 31(6):466\u2013471","journal-title":"Virol Sin"},{"issue":"870","key":"2450_CR141","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.add6593","volume":"18","author":"Y Rui","year":"2025","unstructured":"Rui Y, Shen S, Wang Y, Cheng L, Chen S, Hu Y et al (2025) HIV-1 Vpu and SARS-CoV-2 ORF3a proteins disrupt STING-mediated activation of antiviral NF-\u03baB signaling. Sci Signal 18(870):eadd6593","journal-title":"Sci Signal"},{"issue":"5","key":"2450_CR142","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1080\/15548627.2022.2139921","volume":"19","author":"Z Ma","year":"2023","unstructured":"Ma Z, Bai J, Jiang C, Zhu H, Liu D, Pan M et al (2023) Tegument protein UL21 of alpha-herpesvirus inhibits the innate immunity by triggering CGAS degradation through TOLLIP-mediated selective autophagy. Autophagy 19(5):1512\u20131532","journal-title":"Autophagy"},{"issue":"7","key":"2450_CR143","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41564-022-01136-6","volume":"7","author":"Y Ren","year":"2022","unstructured":"Ren Y, Wang A, Wu D, Wang C, Huang M, Xiong X et al (2022) Dual inhibition of innate immunity and apoptosis by human cytomegalovirus protein UL37x1 enables efficient virus replication. Nat Microbiol 7(7):1041\u20131053","journal-title":"Nat Microbiol"},{"key":"2450_CR144","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00022-20","author":"HM Zou","year":"2020","unstructured":"Zou HM, Huang ZF, Yang Y, Luo WW, Wang SY, Luo MH et al (2020) Human cytomegalovirus protein UL94 targets MITA to evade the antiviral immune response. J Virol. https:\/\/doi.org\/10.1128\/JVI.00022-20 \u00a0IF: 4.1 Q1 B2","journal-title":"J Virol"},{"key":"2450_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9040292","author":"I Lo Cigno","year":"2020","unstructured":"Lo Cigno I, Calati F, Albertini S, Gariglio M (2020) Subversion of host innate immunity by human papillomavirus oncoproteins. Pathogens. https:\/\/doi.org\/10.3390\/pathogens9040292 \u00a0IF: 3.8 Q2 B3","journal-title":"Pathogens"},{"issue":"4","key":"2450_CR146","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jmii.2020.07.010","volume":"54","author":"V Bortnik","year":"2021","unstructured":"Bortnik V, Wu M, Julcher B, Salinas A, Nikolic I, Simpson KJ et al (2021) Loss of HPV type 16 E7 restores cGAS-STING responses in human papilloma virus-positive oropharyngeal squamous cell carcinomas cells. J Microbiol Immunol Infect 54(4):733\u2013739","journal-title":"J Microbiol Immunol Infect"},{"issue":"7","key":"2450_CR147","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1093\/brain\/awae053","volume":"147","author":"E Kong","year":"2024","unstructured":"Kong E, Hua T, Li J, Li Y, Yang M, Ding R et al (2024) HSV-1 reactivation results in post-herpetic neuralgia by upregulating Prmt6 and inhibiting cGAS-STING. Brain 147(7):2552\u20132565","journal-title":"Brain"},{"issue":"4","key":"2450_CR148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011324","volume":"19","author":"J Shi","year":"2023","unstructured":"Shi J, Jia X, He Y, Ma X, Qi X, Li W et al (2023) Immune evasion strategy involving propionylation by the KSHV interferon regulatory factor 1 (vIRF1). PLoS Pathog 19(4):e1011324","journal-title":"PLoS Pathog"},{"issue":"1","key":"2450_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28175","volume":"95","author":"J Su","year":"2023","unstructured":"Su J, Shen S, Hu Y, Chen S, Cheng L, Cai Y et al (2023) SARS-CoV-2 ORF3a inhibits cGAS-STING-mediated autophagy flux and antiviral function. J Med Virol 95(1):e28175","journal-title":"J Med Virol"},{"key":"2450_CR150","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.260682","author":"J Zhu","year":"2023","unstructured":"Zhu J, Chiang C, Gack MU (2023) Viral evasion of the interferon response at a glance. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.260682 \u00a0IF: 3.9 Q3 B3","journal-title":"J Cell Sci"},{"issue":"1","key":"2450_CR151","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/cmi.2016.06","volume":"14","author":"MH Christensen","year":"2017","unstructured":"Christensen MH, Paludan SR (2017) Viral evasion of DNA-stimulated innate immune responses. Cell Mol Immunol 14(1):4\u201313","journal-title":"Cell Mol Immunol"},{"key":"2450_CR152","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13110957","author":"C Lin","year":"2024","unstructured":"Lin C, Zhang C, Chen N, Meurens F, Zhu J, Zheng W (2024) How does African swine fever virus evade the cGAS-STING pathway? Pathogens. https:\/\/doi.org\/10.3390\/pathogens13110957 \u00a0IF: 3.8 Q2 B3","journal-title":"Pathogens"},{"key":"2450_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2024.110317","volume":"602","author":"J Chaudhari","year":"2025","unstructured":"Chaudhari J, Lai DC, Vu HLX (2025) African swine fever viral proteins that inhibit cGAS-STING pathway and type-I interferon production. Virology 602:110317","journal-title":"Virology"},{"key":"2450_CR154","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9070765","author":"H Yu","year":"2021","unstructured":"Yu H, Bruneau RC, Brennan G, Rothenburg S (2021) Battle royale: innate recognition of poxviruses and viral immune evasion. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9070765 \u00a0IF: 4.5 Q2 B3","journal-title":"Biomedicines"},{"key":"2450_CR155","doi-asserted-by":"publisher","DOI":"10.3390\/ani12212935","author":"WR He","year":"2022","unstructured":"He WR, Yuan J, Ma YH, Zhao CY, Yang ZY, Zhang Y et al (2022) Modulation of host antiviral innate immunity by African swine fever virus: a review. Animals. https:\/\/doi.org\/10.3390\/ani12212935 \u00a0IF: 3.2 Q1 B2","journal-title":"Animals"},{"key":"2450_CR156","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.70115","author":"W Zhang","year":"2026","unstructured":"Zhang W, Zhang H, Liao Y, Jiang S, Zhang H, Huang C et al (2026) Microbial metabolites in tumor epigenetic regulation. iMeta. https:\/\/doi.org\/10.1002\/imt2.70115 \u00a0IF: 44.4 Q1 B1","journal-title":"iMeta"},{"issue":"1","key":"2450_CR157","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1146\/annurev-virology-092917-043244","volume":"5","author":"Z Ma","year":"2018","unstructured":"Ma Z, Ni G, Damania B (2018) Innate sensing of DNA virus genomes. Annu Rev Virol 5(1):341\u2013362","journal-title":"Annu Rev Virol"},{"issue":"12","key":"2450_CR158","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1007\/s00204-025-04150-9","volume":"99","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wu S, Wang Y, Wang CX, Zheng W, Yun X et al (2025) Interplay of cGAS-STING and ferroptosis: crosstalk, molecular mechanisms, and therapeutic prospects. Arch Toxicol 99(12):4883\u20134905","journal-title":"Arch Toxicol"},{"key":"2450_CR159","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1005586","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yuan Y, Zhang L (2022) Innate immune evasion by alphaviruses. Front Immunol 13:1005586","journal-title":"Front Immunol"},{"issue":"2","key":"2450_CR160","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011132","volume":"19","author":"H Liu","year":"2023","unstructured":"Liu H, Zhu Z, Xue Q, Yang F, Li Z, Xue Z et al (2023) Innate sensing of picornavirus infection involves cGAS-STING-mediated antiviral responses triggered by mitochondrial DNA release. PLoS Pathog 19(2):e1011132","journal-title":"PLoS Pathog"},{"issue":"5","key":"2450_CR161","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/10409238.2024.2411264","volume":"59","author":"AA Malik","year":"2024","unstructured":"Malik AA, Shariq M, Sheikh JA, Jaiswal U, Fayaz H, Shrivastava G et al (2024) Mechanisms of immune evasion by Mycobacterium tuberculosis: the impact of T7SS and cell wall lipids on host defenses. Crit Rev Biochem Mol Biol 59(5):310\u2013336","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"4","key":"2450_CR162","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/med.22016","volume":"44","author":"X Tian","year":"2024","unstructured":"Tian X, Ai J, Tian X, Wei X (2024) cGAS-STING pathway agonists are promising vaccine adjuvants. Med Res Rev 44(4):1768\u20131799","journal-title":"Med Res Rev"},{"issue":"1","key":"2450_CR163","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2025.2517137","volume":"32","author":"G Sinani","year":"2025","unstructured":"Sinani G, \u015eenel S (2025) Advances in vaccine adjuvant development and future perspectives. Drug Deliv 32(1):2517137","journal-title":"Drug Deliv"},{"issue":"2","key":"2450_CR164","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/COH.0000000000000233","volume":"11","author":"D Sauter","year":"2016","unstructured":"Sauter D, Kirchhoff F (2016) HIV replication: a game of hide and sense. Curr Opin HIV AIDS 11(2):173\u2013181","journal-title":"Curr Opin HIV AIDS"},{"key":"2450_CR165","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.coviro.2017.01.001","volume":"22","author":"N Hertoghs","year":"2017","unstructured":"Hertoghs N, Geijtenbeek TBH, Ribeiro CMS (2017) Interplay between HIV-1 innate sensing and restriction in mucosal dendritic cells: balancing defense and viral transmission. Curr Opin Virol 22:112\u2013119","journal-title":"Curr Opin Virol"},{"key":"2450_CR166","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1224341","volume":"14","author":"L Wang","year":"2023","unstructured":"Wang L, Zhang L (2023) The arms race between bacteria CBASS and bacteriophages. Front Immunol 14:1224341","journal-title":"Front Immunol"},{"issue":"1","key":"2450_CR167","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-025-02264-1","volume":"10","author":"R Chen","year":"2025","unstructured":"Chen R, Zou J, Chen J, Zhong X, Kang R, Tang D (2025) Pattern recognition receptors: function, regulation and therapeutic potential. Signal Transduct Target Ther 10(1):216","journal-title":"Signal Transduct Target Ther"},{"key":"2450_CR168","first-page":"0663","volume":"8","author":"J Zhuang","year":"2025","unstructured":"Zhuang J, Hai Y, Lu X, Sun B, Fan R, Zhang B et al (2025) A self-assembled metabolic regulator reprograms macrophages to combat cytokine storm and boost sepsis immunotherapy. Research (Wash D C) 8:0663","journal-title":"Research (Wash D C)"},{"key":"2450_CR169","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.2147\/DDDT.S521397","volume":"19","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yang R, Cao Y, Li Y, Zhu Y, Zhang Z et al (2025) CGAS-STING targeting offers novel therapeutic opportunities in liver diseases. Drug Des Devel Ther 19:5835\u20135853","journal-title":"Drug Des Devel Ther"},{"key":"2450_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213483","author":"D de Moura Rodrigues","year":"2022","unstructured":"de Moura Rodrigues D, Lacerda-Queiroz N, Couillin I, Riteau N (2022) STING targeting in lung diseases. Cells. https:\/\/doi.org\/10.3390\/cells11213483 \u00a0IF: 6.0 Q2 B2","journal-title":"Cells"},{"issue":"1","key":"2450_CR171","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-025-10051-5","volume":"41","author":"T Yu","year":"2025","unstructured":"Yu T, Fleishman JS, Wang H, Liu X, Huo L (2025) CGAS-STING targeting offers novel therapeutic regimen in sepsis-associated organ dysfunction. Cell Biol Toxicol 41(1):113","journal-title":"Cell Biol Toxicol"},{"key":"2450_CR172","doi-asserted-by":"publisher","first-page":"965726","DOI":"10.3389\/fcvm.2022.965726","volume":"9","author":"Y Du","year":"2022","unstructured":"Du Y, Zhang H, Nie X, Qi Y, Shi S, Han Y et al (2022) Link between sterile inflammation and cardiovascular diseases: Focus on cGAS-STING pathway in the pathogenesis and therapeutic prospect. Front Cardiovasc Med 9:965726","journal-title":"Front Cardiovasc Med"},{"key":"2450_CR173","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1402817","volume":"15","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Shen L, Ruan H, Huang Z (2024) CGAS-STING signaling in cardiovascular diseases. Front Immunol 15:1402817","journal-title":"Front Immunol"},{"issue":"3-4","key":"2450_CR174","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00430-019-00582-0","volume":"208","author":"M Stempel","year":"2019","unstructured":"Stempel M, Chan B, Brinkmann MM (2019) Coevolution pays off: herpesviruses have the license to escape the DNA sensing pathway. Med Microbiol Immunol 208(3\u20134):495\u2013512","journal-title":"Med Microbiol Immunol"},{"key":"2450_CR175","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.931885","volume":"13","author":"L Deng","year":"2022","unstructured":"Deng L, Xu Z, Li F, Zhao J, Jian Z, Deng H et al (2022) Insights on the cGAS-STING signaling pathway during herpesvirus infections. Front Immunol 13:931885","journal-title":"Front Immunol"},{"key":"2450_CR176","first-page":"0895","volume":"8","author":"P Zhao","year":"2025","unstructured":"Zhao P, Li J, He P, Wu Y, Zheng L, Yang X et al (2025) NUFIP1-mediated ribophagy alleviates PANoptosis of CD4(+) T lymphocytes in sepsis via the cGAS-STING pathway. Research (Wash D C) 8:0895","journal-title":"Research (Wash D C)"},{"key":"2450_CR177","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coi.2020.04.002","volume":"66","author":"JB Eaglesham","year":"2020","unstructured":"Eaglesham JB, Kranzusch PJ (2020) Conserved strategies for pathogen evasion of cGAS-STING immunity. Curr Opin Immunol 66:27\u201334","journal-title":"Curr Opin Immunol"},{"key":"2450_CR178","doi-asserted-by":"publisher","first-page":"954581","DOI":"10.3389\/fcimb.2022.954581","volume":"12","author":"Z Ge","year":"2022","unstructured":"Ge Z, Ding S (2022) Regulation of cGAS\/STING signaling and corresponding immune escape strategies of viruses. Front Cell Infect Microbiol 12:954581","journal-title":"Front Cell Infect Microbiol"},{"key":"2450_CR179","doi-asserted-by":"publisher","DOI":"10.3390\/cells12111499","author":"DB Vlad","year":"2023","unstructured":"Vlad DB, Dumitrascu DI, Dumitrascu AL (2023) Golgi\u2019s role in the development of possible new therapies in cancer. Cells. https:\/\/doi.org\/10.3390\/cells12111499 \u00a0IF: 6.0 Q2 B2","journal-title":"Cells"},{"issue":"5","key":"2450_CR180","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/14760584.2021.1902314","volume":"20","author":"Y Qi","year":"2021","unstructured":"Qi Y, Fox CB (2021) Development of thermostable vaccine adjuvants. Expert Rev Vaccines 20(5):497\u2013517","journal-title":"Expert Rev Vaccines"},{"key":"2450_CR181","doi-asserted-by":"publisher","first-page":"1628481","DOI":"10.3389\/fcimb.2025.1628481","volume":"15","author":"Q Xu","year":"2025","unstructured":"Xu Q, Zhu J (2025) The cGAS-STING signaling pathway in the regulation of pulmonary infections: a systematic review. Front Cell Infect Microbiol 15:1628481","journal-title":"Front Cell Infect Microbiol"},{"key":"2450_CR182","doi-asserted-by":"publisher","DOI":"10.3390\/v16060855","author":"HJ Lee","year":"2024","unstructured":"Lee HJ, Park JH, Park IH, Shin OS (2024) Stimulator of interferon gene agonists induce an innate antiviral response against influenza viruses. Viruses. https:\/\/doi.org\/10.3390\/v16060855 \u00a0IF: 3.8 Q2 B3","journal-title":"Viruses"},{"issue":"9","key":"2450_CR183","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1016\/j.apsb.2025.07.001","volume":"15","author":"Y Gao","year":"2025","unstructured":"Gao Y, Zhang J (2025) The role of SARS-CoV-2 main protease in innate immune regulation: from molecular mechanisms to therapeutic implications. Acta Pharm Sin B 15(9):4497\u20134510","journal-title":"Acta Pharm Sin B"},{"key":"2450_CR184","doi-asserted-by":"publisher","first-page":"1172739","DOI":"10.3389\/fcimb.2023.1172739","volume":"13","author":"L Amurri","year":"2023","unstructured":"Amurri L, Horvat B, Iampietro M (2023) Interplay between RNA viruses and cGAS\/STING axis in innate immunity. Front Cell Infect Microbiol 13:1172739","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"2450_CR185","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1021\/acsinfecdis.4c00504","volume":"10","author":"R Broeckel","year":"2024","unstructured":"Broeckel R, Browne A, Sucoloski S, Cantizani J, Simpson JK, Pesiridis S et al (2024) STING agonist induced innate immune responses drive anti-respiratory virus activity in vitro with limited antiviral efficacy in vivo. ACS Infect Dis 10(9):3392\u20133407","journal-title":"ACS Infect Dis"},{"key":"2450_CR186","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1268429","volume":"14","author":"P Ruan","year":"2023","unstructured":"Ruan P, Wang M, Cheng A, Zhao X, Yang Q, Wu Y et al (2023) Mechanism of herpesvirus UL24 protein regulating viral immune escape and virulence. Front Microbiol 14:1268429","journal-title":"Front Microbiol"},{"issue":"5","key":"2450_CR187","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1615\/CritRevImmunol.2024052486","volume":"44","author":"T Nguyen","year":"2024","unstructured":"Nguyen T, Chen PC, Pham J, Kaur K, Raman SS, Jewett A et al (2024) Current and future states of natural killer cell-based immunotherapy in hepatocellular carcinoma. Crit Rev Immunol 44(5):71\u201385","journal-title":"Crit Rev Immunol"},{"key":"2450_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114551","volume":"154","author":"S Losarwar","year":"2025","unstructured":"Losarwar S, Pancholi B, Babu R, Garabadu D (2025) Mitochondria-dependent innate immunity: a potential therapeutic target in Flavivirus infection. Int Immunopharmacol 154:114551","journal-title":"Int Immunopharmacol"},{"issue":"19","key":"2450_CR189","doi-asserted-by":"publisher","first-page":"e2300260","DOI":"10.1002\/adhm.202300260","volume":"12","author":"Y Li","year":"2023","unstructured":"Li Y, Li X, Yi J, Cao Y, Qin Z, Zhong Z et al (2023) Nanoparticle-mediated STING activation for cancer immunotherapy. Adv Healthc Mater 12(19):e2300260","journal-title":"Adv Healthc Mater"},{"issue":"8","key":"2450_CR190","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.202100133","volume":"21","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Zhou Y, Li T, Ge Z (2021) Nanoparticle-mediated STING agonist delivery for enhanced cancer immunotherapy. Macromol Biosci 21(8):e2100133","journal-title":"Macromol Biosci"},{"issue":"12","key":"2450_CR191","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1002\/ptr.7624","volume":"36","author":"JA Nazeam","year":"2022","unstructured":"Nazeam JA, Singab ANB (2022) Immunostimulant plant proteins: potential candidates as vaccine adjuvants. Phytother Res 36(12):4345\u20134360","journal-title":"Phytother Res"},{"issue":"5","key":"2450_CR192","doi-asserted-by":"publisher","first-page":"e1894","DOI":"10.1002\/wnan.1894","volume":"15","author":"MZ Yu","year":"2023","unstructured":"Yu MZ, Wang NN, Zhu JQ, Lin YX (2023) The clinical progress and challenges of mRNA vaccines. Wiley Interdiscip Rev Nanomed Nanobiotechnol 15(5):e1894","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"4","key":"2450_CR193","first-page":"439","volume":"52","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Li X (2023) Research progress in mRNA drug modification and delivery systems. Zhejiang Da Xue Xue Bao Yi Xue Ban 52(4):439\u2013450","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"2450_CR194","doi-asserted-by":"publisher","first-page":"941077","DOI":"10.3389\/fbioe.2022.941077","volume":"10","author":"L Shao","year":"2022","unstructured":"Shao L, Shen S, Liu H (2022) Recent advances in PLGA micro\/nanoparticle delivery systems as novel therapeutic approach for drug-resistant tuberculosis. Front Bioeng Biotechnol 10:941077","journal-title":"Front Bioeng Biotechnol"},{"key":"2450_CR195","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cytogfr.2025.06.002","volume":"85","author":"Y Wu","year":"2025","unstructured":"Wu Y, Lu WM, Cui QR, Zhou J, Lu GD (2025) Metabolic regulation of cGAS-STING signaling in the tumor microenvironment: dual immune roles and therapeutic implications. Cytokine Growth Factor Rev 85:43\u201355","journal-title":"Cytokine Growth Factor Rev"},{"key":"2450_CR196","doi-asserted-by":"crossref","unstructured":"Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M et al (2020) Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science 367(6480).","DOI":"10.1126\/science.aau0810"},{"issue":"10","key":"2450_CR197","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.tips.2025.08.009","volume":"46","author":"XF Yu","year":"2025","unstructured":"Yu XF, Wang S, Ye R, Wei W (2025) Viral evasion of cGAS-STING pathway: opportunities for intervention. Trends Pharmacol Sci 46(10):989\u20131003","journal-title":"Trends Pharmacol Sci"},{"issue":"16","key":"2450_CR198","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1158\/1078-0432.CCR-24-3630","volume":"31","author":"KJ Harrington","year":"2025","unstructured":"Harrington KJ, Champiat S, Brody JD, Cho BC, Romano E, Golan T et al (2025) Phase I and II clinical studies of the STING agonist ulevostinag with and without pembrolizumab in participants with advanced or metastatic solid tumors or lymphomas. Clin Cancer Res 31(16):3400\u20133411","journal-title":"Clin Cancer Res"},{"key":"2450_CR199","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jconrel.2021.09.033","volume":"339","author":"M Petrovic","year":"2021","unstructured":"Petrovic M, Borchard G, Jordan O (2021) Considerations for the delivery of STING ligands in cancer immunotherapy. J Control Release 339:235\u2013247","journal-title":"J Control Release"},{"issue":"13","key":"2450_CR200","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-23-0118","volume":"29","author":"JJ Luke","year":"2023","unstructured":"Luke JJ, Piha-Paul SA, Medina T, Verschraegen CF, Varterasian M, Brennan AM et al (2023) Phase I study of SYNB1891, an engineered E. coli Nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies. Clin Cancer Res 29(13):2435\u20132444","journal-title":"Clin Cancer Res"},{"key":"2450_CR201","doi-asserted-by":"publisher","first-page":"0016","DOI":"10.34133\/bmef.0016","volume":"4","author":"WCW Chan","year":"2023","unstructured":"Chan WCW (2023) Principles of nanoparticle delivery to solid tumors. BME Front 4:0016","journal-title":"BME Front"},{"key":"2450_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102309","volume":"31","author":"EM Miller","year":"2021","unstructured":"Miller EM, Samec TM, Alexander-Bryant AA (2021) Nanoparticle delivery systems to combat drug resistance in ovarian cancer. Nanomedicine (Lond) 31:102309","journal-title":"Nanomedicine (Lond)"},{"key":"2450_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2023.103042","volume":"85","author":"MY Mata Corral","year":"2024","unstructured":"Mata Corral MY, Alvarez DE, Poon W (2024) Quantifying nanoparticle delivery: challenges, tools, and advances. Curr Opin Biotechnol 85:103042","journal-title":"Curr Opin Biotechnol"},{"key":"2450_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.111647","volume":"128","author":"H Vasiyani","year":"2025","unstructured":"Vasiyani H, Wadhwa B (2025) STING activation and overcoming the challenges associated with STING agonists using ADC (antibody-drug conjugate) and other delivery systems. Cell Signal 128:111647","journal-title":"Cell Signal"},{"key":"2450_CR205","doi-asserted-by":"publisher","first-page":"8641","DOI":"10.2147\/IJN.S471900","volume":"19","author":"C Wang","year":"2024","unstructured":"Wang C, Zhang Y, Kong W, Rong X, Zhong Z, Jiang L et al (2024) Delivery of miRNAs using nanoparticles for the treatment of osteosarcoma. Int J Nanomed 19:8641\u20138660","journal-title":"Int J Nanomed"},{"key":"2450_CR206","doi-asserted-by":"publisher","first-page":"10771","DOI":"10.2147\/IJN.S535460","volume":"20","author":"W Zhao","year":"2025","unstructured":"Zhao W, Tang X, Qin Y, Wang X, Zhong K, Gong N et al (2025) Nanomaterials application for STING pathway-based tumor immunotherapy. Int J Nanomed 20:10771\u201310793","journal-title":"Int J Nanomed"},{"issue":"11","key":"2450_CR207","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1007\/s13346-024-01591-0","volume":"14","author":"R Cheng","year":"2024","unstructured":"Cheng R, Wang S (2024) Cell-mediated nanoparticle delivery systems: towards precision nanomedicine. Drug Deliv Transl Res 14(11):3032\u20133054","journal-title":"Drug Deliv Transl Res"},{"issue":"9","key":"2450_CR208","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1158\/1078-0432.CCR-24-2449","volume":"31","author":"RA Bukhalid","year":"2056","unstructured":"Bukhalid RA, Duvall JR, Lancaster K, Catcott KC, Malli Cetinbas N, Monnell T et al (2056) XMT-2056, a HER2-directed STING agonist antibody-drug conjugate, induces innate antitumor immune responses by acting on cancer cells and tumor-resident immune cells. Clin Cancer Res 31(9):1766\u20131782","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2450_CR209","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/s41386-022-01311-7","volume":"47","author":"V Kasina","year":"2022","unstructured":"Kasina V, Mownn RJ, Bahal R, Sartor GC (2022) Nanoparticle delivery systems for substance use disorder. Neuropsychopharmacology 47(8):1431\u20131439","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"2450_CR210","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s10147-020-01666-1","volume":"25","author":"H Sato","year":"2020","unstructured":"Sato H, Okonogi N, Nakano T (2020) Rationale of combination of anti-PD-1\/PD-L1 antibody therapy and radiotherapy for cancer treatment. Int J Clin Oncol 25(5):801\u2013809","journal-title":"Int J Clin Oncol"},{"issue":"15","key":"2450_CR211","doi-asserted-by":"publisher","first-page":"10439","DOI":"10.1021\/acsnano.3c11374","volume":"18","author":"X Sun","year":"2024","unstructured":"Sun X, Huang X, Park KS, Zhou X, Kennedy AA, Pretto CD et al (2024) Self-assembled STING-activating coordination nanoparticles for cancer immunotherapy and vaccine applications. ACS Nano 18(15):10439\u201310453","journal-title":"ACS Nano"},{"issue":"52","key":"2450_CR212","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202305668","volume":"35","author":"M Cui","year":"2023","unstructured":"Cui M, Tang D, Wang B, Zhang H, Liang G, Xiao H (2023) Bioorthogonal guided activation of cGAS-STING by AIE photosensitizer nanoparticles for targeted tumor therapy and imaging. Adv Mater 35(52):e2305668","journal-title":"Adv Mater"},{"key":"2450_CR213","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116211","volume":"267","author":"D Guan","year":"2024","unstructured":"Guan D, Fang L, Feng M, Guo S, Xie L, Chen C et al (2024) Ecto-nucleotide pyrophosphatase\/phosphodiesterase 1 inhibitors: research progress and prospects. Eur J Med Chem 267:116211","journal-title":"Eur J Med Chem"},{"issue":"1","key":"2450_CR214","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02366-y","volume":"24","author":"Q Zeng","year":"2025","unstructured":"Zeng Q, Liu M, Wang Z, Zhou R, Ai K (2025) Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated STING agonist synergy. Mol Cancer 24(1):176","journal-title":"Mol Cancer"},{"key":"2450_CR215","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1342647","volume":"15","author":"T Li","year":"2024","unstructured":"Li T, Zhang W, Niu M, Wu Y, Deng X, Zhou J (2024) STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance. Front Immunol 15:1342647","journal-title":"Front Immunol"},{"key":"2450_CR216","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071590","author":"FT And\u00f3n","year":"2022","unstructured":"And\u00f3n FT, Leon S, Ummarino A, Redin E, Allavena P, Serrano D et al (2022) Innate and adaptive responses of intratumoral immunotherapy with endosomal Toll-like receptor agonists. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10071590 \u00a0IF: 4.5 Q2 B3","journal-title":"Biomedicines"},{"issue":"2","key":"2450_CR217","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1158\/0008-5472.CAN-18-1003","volume":"79","author":"J Shen","year":"2019","unstructured":"Shen J, Zhao W, Ju Z, Wang L, Peng Y, Labrie M et al (2019) PARPi triggers the STING-dependent immune response and enhances the therapeutic efficacy of immune checkpoint blockade independent of BRCAness. Cancer Res 79(2):311\u2013319","journal-title":"Cancer Res"},{"key":"2450_CR218","first-page":"1265","volume":"9","author":"J Zhou","year":"2026","unstructured":"Zhou J, He J, Lu Y, Yi C, Chang X, Tao L et al (2026) Methyltransferase-Like 3 Inhibition-Activated cGAS\/STING Axis Enhances Immunotherapy and Poly(ADP-Ribose) Polymerase Inhibitor Sensitivity in Lung Adenocarcinoma. Research (Wash D C) 9:1265","journal-title":"Research (Wash D C)"},{"issue":"7","key":"2450_CR219","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/intimm\/dxac012","volume":"34","author":"B Temizoz","year":"2022","unstructured":"Temizoz B, Hioki K, Kobari S, Jounai N, Kusakabe T, Lee MSJ et al (2022) Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation. Int Immunol 34(7):353\u2013364","journal-title":"Int Immunol"},{"issue":"4","key":"2450_CR220","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","volume":"28","author":"F Meric-Bernstam","year":"2022","unstructured":"Meric-Bernstam F, Sweis RF, Hodi FS, Messersmith WA, Andtbacka RHI, Ingham M et al (2022) Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas. Clin Cancer Res 28(4):677\u2013688","journal-title":"Clin Cancer Res"},{"issue":"7736","key":"2450_CR221","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","volume":"564","author":"JM Ramanjulu","year":"2018","unstructured":"Ramanjulu JM, Pesiridis GS, Yang J, Concha N, Singhaus R, Zhang SY et al (2018) Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature 564(7736):439\u2013443","journal-title":"Nature"},{"issue":"11","key":"2450_CR222","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187532","volume":"12","author":"JR Baird","year":"2017","unstructured":"Baird JR, Feng Z, Xiao HD, Friedman D, Cottam B, Fox BA et al (2017) STING expression and response to treatment with STING ligands in premalignant and malignant disease. PLoS ONE 12(11):e0187532","journal-title":"PLoS ONE"},{"issue":"1","key":"2450_CR223","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/0008-5472.CAN-14-3619","volume":"76","author":"JR Baird","year":"2016","unstructured":"Baird JR, Friedman D, Cottam B, Dubensky TW Jr., Kanne DB, Bambina S et al (2016) Radiotherapy combined with novel STING-targeting oligonucleotides results in regression of established tumors. Cancer Res 76(1):50\u201361","journal-title":"Cancer Res"},{"issue":"7","key":"2450_CR224","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nnano.2017.52","volume":"12","author":"M Luo","year":"2017","unstructured":"Luo M, Wang H, Wang Z, Cai H, Lu Z, Li Y et al (2017) A STING-activating nanovaccine for cancer immunotherapy. Nat Nanotechnol 12(7):648\u2013654","journal-title":"Nat Nanotechnol"},{"issue":"5","key":"2450_CR225","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1158\/2159-8290.CD-20-0387","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Duran MA, Dhanota N, Chatila WK, Bettigole SE, Kwon J et al (2021) Metastasis and immune evasion from extracellular cGAMP hydrolysis. Cancer Discov 11(5):1212\u20131227","journal-title":"Cancer Discov"},{"key":"2450_CR226","doi-asserted-by":"crossref","unstructured":"Pan BS, Perera SA, Piesvaux JA, Presland JP, Schroeder GK, Cumming JN et al (2020) An orally available non-nucleotide STING agonist with antitumor activity. Science 369(6506)","DOI":"10.1126\/science.aba6098"},{"issue":"6506","key":"2450_CR227","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1126\/science.abb4255","volume":"369","author":"EN Chin","year":"2020","unstructured":"Chin EN, Yu C, Vartabedian VF, Jia Y, Kumar M, Gamo AM et al (2020) Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic. Science 369(6506):993\u2013999","journal-title":"Science"},{"key":"2450_CR228","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2105465118","author":"Z Hong","year":"2021","unstructured":"Hong Z, Mei J, Li C, Bai G, Maimaiti M, Hu H et al (2021) STING inhibitors target the cyclic dinucleotide binding pocket. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2105465118 \u00a0IF: 9.5 Q1 B1","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2450_CR229","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1016\/j.celrep.2018.11.047","volume":"25","author":"KE Sivick","year":"2018","unstructured":"Sivick KE, Desbien AL, Glickman LH, Reiner GL, Corrales L, Surh NH et al (2018) Magnitude of therapeutic STING activation determines CD8(+) T cell-mediated anti-tumor immunity. Cell Rep 25(11):3074\u201385.e5","journal-title":"Cell Rep"},{"issue":"6","key":"2450_CR230","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1021\/acs.chemrev.1c00750","volume":"122","author":"KM Garland","year":"2022","unstructured":"Garland KM, Sheehy TL, Wilson JT (2022) Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy. Chem Rev 122(6):5977\u20136039","journal-title":"Chem Rev"},{"issue":"19","key":"2450_CR231","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202400255","volume":"25","author":"C Huang","year":"2024","unstructured":"Huang C, Tong T, Ren L, Wang H (2024) STING-activating small molecular therapeutics for cancer immunotherapy. ChemBioChem 25(19):e202400255","journal-title":"ChemBioChem"},{"issue":"1","key":"2450_CR232","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s40425-019-0573-5","volume":"7","author":"W Jing","year":"2019","unstructured":"Jing W, McAllister D, Vonderhaar EP, Palen K, Riese MJ, Gershan J et al (2019) STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models. J Immunother Cancer 7(1):115","journal-title":"J Immunother Cancer"},{"issue":"7","key":"2450_CR233","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1021\/acsnano.4c10202","volume":"19","author":"X Lu","year":"2025","unstructured":"Lu X, Xia H, Gao W, Pan X, Yan Y, Zhang R et al (2025) A pH-responsive and guanidinium-rich nanoadjuvant efficiently delivers STING agonist for cancer immunotherapy. ACS Nano 19(7):6758\u20136770","journal-title":"ACS Nano"},{"key":"2450_CR234","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.actbio.2022.11.019","volume":"155","author":"J Xia","year":"2023","unstructured":"Xia J, Wang L, Shen T, Li P, Zhu P, Xie S et al (2023) Integrated manganese (III)-doped nanosystem for optimizing photothermal ablation: amplifying hyperthermia-induced STING pathway and enhancing antitumor immunity. Acta Biomater 155:601\u2013617","journal-title":"Acta Biomater"},{"key":"2450_CR235","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1584245","volume":"16","author":"D Li","year":"2025","unstructured":"Li D, Li Y, Cang J, Yan X, Wu F, Sun X et al (2025) Synergistic chemo-immunotherapy for osteosarcoma via a pH-responsive multi-component nanoparticle system. Front Pharmacol 16:1584245","journal-title":"Front Pharmacol"},{"issue":"43","key":"2450_CR236","doi-asserted-by":"publisher","first-page":"29439","DOI":"10.1021\/acsnano.3c12337","volume":"18","author":"SL Cheng","year":"2024","unstructured":"Cheng SL, Lee HM, Li CP, Lin MW, Chou MY, Yen YT et al (2024) Robust and sustained STING pathway activation via hydrogel-based in situ vaccination for cancer immunotherapy. ACS Nano 18(43):29439\u201329456","journal-title":"ACS Nano"},{"key":"2450_CR237","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120542","volume":"268","author":"J Zhao","year":"2021","unstructured":"Zhao J, Ma S, Xu Y, Si X, Yao H, Huang Z et al (2021) In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy. Biomaterials 268:120542","journal-title":"Biomaterials"},{"key":"2450_CR238","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002852","author":"T Nakamura","year":"2021","unstructured":"Nakamura T, Sato T, Endo R, Sasaki S, Takahashi N, Sato Y et al (2021) STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-002852 \u00a0IF: 11.7 Q1 B1","journal-title":"J Immunother Cancer"},{"issue":"12","key":"2450_CR239","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300028","volume":"12","author":"Y Gu","year":"2023","unstructured":"Gu Y, Lin S, Wu Y, Xu P, Zhu W, Wang Y et al (2023) Targeting STING activation by antigen-inspired MnO(2) nanovaccines optimizes tumor radiotherapy. Adv Healthc Mater 12(12):e2300028","journal-title":"Adv Healthc Mater"},{"issue":"12","key":"2450_CR240","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.7150\/thno.73104","volume":"12","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Guo Y, Chen L, Zhang X, Wu W, Yang Z et al (2022) Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy. Theranostics 12(12):5488\u20135503","journal-title":"Theranostics"},{"issue":"10","key":"2450_CR241","doi-asserted-by":"publisher","first-page":"e2412654","DOI":"10.1002\/adma.202412654","volume":"37","author":"M Zhang","year":"2025","unstructured":"Zhang M, Wang Y, Li B, Yang B, Zhao M, Li B et al (2025) STING-activating polymers boost lymphatic delivery of mRNA vaccine to potentiate cancer immunotherapy. Adv Mater 37(10):e2412654","journal-title":"Adv Mater"},{"issue":"1","key":"2450_CR242","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-025-02242-9","volume":"24","author":"C Qiu","year":"2025","unstructured":"Qiu C, Xia F, Tu Q, Tang H, Liu Y, Liu H et al (2025) Multimodal lung cancer theranostics via manganese phosphate\/quercetin particle. Mol Cancer 24(1):43","journal-title":"Mol Cancer"},{"issue":"7","key":"2450_CR243","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1591875","volume":"8","author":"PK Bommareddy","year":"2019","unstructured":"Bommareddy PK, Zloza A, Rabkin SD, Kaufman HL (2019) Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma. Oncoimmunology 8(7):e1591875","journal-title":"Oncoimmunology"},{"key":"2450_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.128101","volume":"44","author":"X Wang","year":"2021","unstructured":"Wang X, Liu Y, Han X, Zou G, Zhu W, Shen H et al (2021) Small molecule approaches to treat autoimmune and inflammatory diseases (Part II): nucleic acid sensing antagonists and inhibitors. Bioorg Med Chem Lett 44:128101","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"2450_CR245","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202218128","volume":"62","author":"W Su","year":"2023","unstructured":"Su W, Tan M, Wang Z, Zhang J, Huang W, Song H et al (2023) Targeted degradation of PD-L1 and activation of the STING pathway by carbon-dot-based PROTACs for cancer immunotherapy. Angew Chem Int Ed Engl 62(11):e202218128","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7713","key":"2450_CR246","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","volume":"559","author":"SM Haag","year":"2018","unstructured":"Haag SM, Gulen MF, Reymond L, Gibelin A, Abrami L, Decout A et al (2018) Targeting STING with covalent small-molecule inhibitors. Nature 559(7713):269\u2013273","journal-title":"Nature"},{"issue":"1","key":"2450_CR247","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41467-017-00833-9","volume":"8","author":"J Vincent","year":"2017","unstructured":"Vincent J, Adura C, Gao P, Luz A, Lama L, Asano Y et al (2017) Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice. Nat Commun 8(1):750","journal-title":"Nat Commun"},{"issue":"1","key":"2450_CR248","doi-asserted-by":"publisher","first-page":"e2400230","DOI":"10.1002\/adbi.202400230","volume":"9","author":"B Mdkhana","year":"2025","unstructured":"Mdkhana B, Saheb Sharif-Askari N, Cagliani R, Al-Sheakly BKS, Ramakrishnan RK, Saheb Sharif-Askari F et al (2025) Inhibiting DNA sensing pathway controls steroid hyporesponsive lung inflammation. Adv Biol (Weinh) 9(1):e2400230","journal-title":"Adv Biol (Weinh)"},{"issue":"2","key":"2450_CR249","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2020.01.014","volume":"52","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Fei M, Zhang G, Liang WC, Lin W, Wu Y et al (2020) Blockade of the phagocytic receptor MerTK on tumor-associated macrophages enhances P2X7R-dependent STING activation by tumor-derived cGAMP. Immunity 52(2):357\u201373.e9","journal-title":"Immunity"},{"key":"2450_CR250","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1150412","volume":"14","author":"N Austriaco","year":"2023","unstructured":"Austriaco N (2023) Yeast oral vaccines against infectious diseases. Front Microbiol 14:1150412","journal-title":"Front Microbiol"},{"key":"2450_CR251","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.105718","volume":"159","author":"M Behzadi","year":"2021","unstructured":"Behzadi M, Vakili B, Ebrahiminezhad A, Nezafat N (2021) Iron nanoparticles as novel vaccine adjuvants. Eur J Pharm Sci 159:105718","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"2450_CR252","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2395081","volume":"20","author":"B Akache","year":"2024","unstructured":"Akache B, McCluskie MJ (2024) Sulfated lactosyl archaeol (SLA) archaeosomes as a vaccine adjuvant. Hum Vaccin Immunother 20(1):2395081","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"2450_CR253","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/14760584.2023.2238807","volume":"22","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, Zou F, Xia N, Li S (2023) In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives. Expert Rev Vaccines 22(1):681\u2013695","journal-title":"Expert Rev Vaccines"},{"key":"2450_CR254","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00008","volume":"10","author":"K Vermaelen","year":"2019","unstructured":"Vermaelen K (2019) Vaccine strategies to improve anti-cancer cellular immune responses. Front Immunol 10:8","journal-title":"Front Immunol"},{"key":"2450_CR255","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10071120","author":"J Fan","year":"2022","unstructured":"Fan J, Jin S, Gilmartin L, Toth I, Hussein WM, Stephenson RJ (2022) Advances in infectious disease vaccine adjuvants. Vaccines (Basel). https:\/\/doi.org\/10.3390\/vaccines10071120 \u00a0IF: 3.5 Q2 B3","journal-title":"Vaccines (Basel)"},{"issue":"23","key":"2450_CR256","doi-asserted-by":"publisher","first-page":"e2201895","DOI":"10.1002\/advs.202201895","volume":"9","author":"T Su","year":"2022","unstructured":"Su T, Cheng F, Qi J, Zhang Y, Zhou S, Mei L et al (2022) Responsive multivesicular polymeric nanovaccines that codeliver STING agonists and neoantigens for combination tumor immunotherapy. Adv Sci (Weinh) 9(23):e2201895","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"2450_CR257","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.7150\/thno.107200","volume":"15","author":"N Wang","year":"2025","unstructured":"Wang N, Yu H, Yin J, Yu X (2025) pH-responsive nano-vaccine combined with anti-PD-1 antibodies for enhanced immunotherapy of breast cancer. Theranostics 15(12):6022\u20136043","journal-title":"Theranostics"},{"issue":"44","key":"2450_CR258","doi-asserted-by":"publisher","first-page":"30701","DOI":"10.1021\/acsnano.4c09902","volume":"18","author":"Z Luo","year":"2024","unstructured":"Luo Z, Lin Y, Meng Y, Li M, Ren H, Shi H et al (2024) Spleen-targeted mRNA vaccine doped with manganese adjuvant for robust anticancer immunity in vivo. ACS Nano 18(44):30701\u201330715","journal-title":"ACS Nano"},{"issue":"17","key":"2450_CR259","doi-asserted-by":"publisher","first-page":"e2206521","DOI":"10.1002\/advs.202206521","volume":"10","author":"HH Tsai","year":"2023","unstructured":"Tsai HH, Huang PH, Lin LC, Yao BY, Liao WT, Pai CH et al (2023) Lymph node follicle-targeting STING agonist nanoshells enable single-shot M2e vaccination for broad and durable influenza protection. Adv Sci (Weinh) 10(17):e2206521","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"2450_CR260","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","volume":"30","author":"M Lv","year":"2020","unstructured":"Lv M, Chen M, Zhang R, Zhang W, Wang C, Zhang Y et al (2020) Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy. Cell Res 30(11):966\u2013979","journal-title":"Cell Res"},{"issue":"1","key":"2450_CR261","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-01049-x","volume":"9","author":"S Zhou","year":"2024","unstructured":"Zhou S, Cao Q, Zhang Z, Du Y, Hou Y, Zhang X et al (2024) The adjuvant effect of manganese on tuberculosis subunit vaccine Bfrb-GrpE. NPJ Vaccines 9(1):248","journal-title":"NPJ Vaccines"},{"issue":"5","key":"2450_CR262","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/PPO.0000000000000620","volume":"28","author":"DG Wallington","year":"2022","unstructured":"Wallington DG, Contessa JN, Hayman TJ (2022) STING agonists in head and neck squamous cell carcinoma. Cancer J 28(5):401\u2013406","journal-title":"Cancer J"},{"issue":"7","key":"2450_CR263","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/infdis\/jiz116","volume":"221","author":"RJ Dey","year":"2020","unstructured":"Dey RJ, Dey B, Singh AK, Praharaj M, Bishai W (2020) Bacillus Calmette-Gu\u00e9rin overexpressing an endogenous stimulator of interferon genes agonist provides enhanced protection against pulmonary tuberculosis. J Infect Dis 221(7):1048\u20131056","journal-title":"J Infect Dis"},{"issue":"26","key":"2450_CR264","doi-asserted-by":"publisher","first-page":"e2402358","DOI":"10.1002\/adhm.202402358","volume":"14","author":"TS Howlett","year":"2025","unstructured":"Howlett TS, Kumari S, Ehrman RN, Masson J, Izzo L, Wang T et al (2025) Mn and Zn-doped multivariate metal-organic framework as a metalloimmunological adjuvant to promote protection against tuberculosis infection. Adv Healthc Mater 14(26):e2402358","journal-title":"Adv Healthc Mater"},{"issue":"9","key":"2450_CR265","doi-asserted-by":"publisher","first-page":"8579","DOI":"10.1021\/acsnano.4c14102","volume":"19","author":"X Xu","year":"2025","unstructured":"Xu X, Wang X, Liao YP, Luo L, Nel AE (2025) Reprogramming the tolerogenic immune response against pancreatic cancer metastases by lipid nanoparticles delivering a STING agonist plus mutant KRAS mRNA. ACS Nano 19(9):8579\u20138594","journal-title":"ACS Nano"},{"key":"2450_CR266","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1485546","volume":"15","author":"B Wang","year":"2024","unstructured":"Wang B, Yu W, Jiang H, Meng X, Tang D, Liu D (2024) Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects. Front Immunol 15:1485546","journal-title":"Front Immunol"},{"key":"2450_CR267","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1069356","volume":"12","author":"SE Fenton","year":"2022","unstructured":"Fenton SE, VanderWeele DJ (2022) Antibody-drug conjugates and predictive biomarkers in advanced urothelial carcinoma. Front Oncol 12:1069356","journal-title":"Front Oncol"},{"issue":"1","key":"2450_CR268","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13045-020-00916-z","volume":"13","author":"M Jiang","year":"2020","unstructured":"Jiang M, Chen P, Wang L, Li W, Chen B, Liu Y et al (2020) cGAS-STING, an important pathway in cancer immunotherapy. J Hematol Oncol 13(1):81","journal-title":"J Hematol Oncol"},{"key":"2450_CR269","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194906","author":"CW Kim","year":"2021","unstructured":"Kim CW, Chon HJ, Kim C (2021) Combination immunotherapies to overcome intrinsic resistance to checkpoint blockade in microsatellite stable colorectal cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13194906 \u00a0IF: 4.8 Q2 B3","journal-title":"Cancers (Basel)"},{"key":"2450_CR270","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00238","volume":"11","author":"MM Walker","year":"2020","unstructured":"Walker MM, Kim S, Crisler WJ, Nguyen K, Lenz LL, Cambier JC et al (2020) Selective loss of responsiveness to exogenous but not endogenous cyclic-dinucleotides in mice expressing STING-R231H. Front Immunol 11:238","journal-title":"Front Immunol"},{"issue":"1","key":"2450_CR271","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/cas.14680","volume":"112","author":"JM Lubbers","year":"2021","unstructured":"Lubbers JM, Koopman B, de Klerk-Sluis JM, van Rooij N, Plat A, Pijper H et al (2021) Association of homozygous variants of STING1 with outcome in human cervical cancer. Cancer Sci 112(1):61\u201371","journal-title":"Cancer Sci"},{"key":"2450_CR272","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111591","volume":"182","author":"X Cui","year":"2019","unstructured":"Cui X, Zhang R, Cen S, Zhou J (2019) STING modulators: predictive significance in drug discovery. Eur J Med Chem 182:111591","journal-title":"Eur J Med Chem"},{"issue":"6","key":"2450_CR273","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nrmicro.2016.45","volume":"14","author":"YK Chan","year":"2016","unstructured":"Chan YK, Gack MU (2016) Viral evasion of intracellular DNA and RNA sensing. Nat Rev Microbiol 14(6):360\u2013373","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"2450_CR274","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/2159-8290.CD-18-0689","volume":"9","author":"S Kitajima","year":"2019","unstructured":"Kitajima S, Ivanova E, Guo S, Yoshida R, Campisi M, Sundararaman SK et al (2019) Suppression of STING associated with LKB1 loss in KRAS-driven lung cancer. Cancer Discov 9(1):34\u201345","journal-title":"Cancer Discov"},{"key":"2450_CR275","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2013598118","author":"R Falahat","year":"2021","unstructured":"Falahat R, Berglund A, Putney RM, Perez-Villarroel P, Aoyama S, Pilon-Thomas S et al (2021) Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2013598118 \u00a0IF: 9.5 Q1 B1","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2450_CR276","doi-asserted-by":"publisher","first-page":"799","DOI":"10.32604\/or.2024.045356","volume":"32","author":"S Stickler","year":"2024","unstructured":"Stickler S, Rath B, Hamilton G (2024) Targeting KRAS in pancreatic cancer. Oncol Res 32(5):799\u2013805","journal-title":"Oncol Res"},{"issue":"1","key":"2450_CR277","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01489-2","volume":"21","author":"M Yi","year":"2022","unstructured":"Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K (2022) Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions. Mol Cancer 21(1):28","journal-title":"Mol Cancer"},{"key":"2450_CR278","doi-asserted-by":"publisher","first-page":"1357343","DOI":"10.3389\/fcvm.2024.1357343","volume":"11","author":"DT Tran","year":"2024","unstructured":"Tran DT, Batchu SN, Advani A (2024) Interferons and interferon-related pathways in heart disease. Front Cardiovasc Med 11:1357343","journal-title":"Front Cardiovasc Med"},{"issue":"16","key":"2450_CR279","doi-asserted-by":"publisher","first-page":"9389","DOI":"10.1093\/nar\/gkab689","volume":"49","author":"D Bhowmik","year":"2021","unstructured":"Bhowmik D, Du M, Tian Y, Ma S, Wu J, Chen Z et al (2021) Cooperative DNA binding mediated by KicGAS\/ORF52 oligomerization allows inhibition of DNA-induced phase separation and activation of cGAS. Nucleic Acids Res 49(16):9389\u20139403","journal-title":"Nucleic Acids Res"},{"key":"2450_CR280","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00318","volume":"7","author":"S Jittavisutthikul","year":"2016","unstructured":"Jittavisutthikul S, Seesuay W, Thanongsaksrikul J, Thueng-In K, Srimanote P, Werner RG et al (2016) Human transbodies to HCV NS3\/4A protease inhibit viral replication and restore host innate immunity. Front Immunol 7:318","journal-title":"Front Immunol"},{"issue":"24","key":"2450_CR281","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1111\/bph.15673","volume":"178","author":"Y Pan","year":"2021","unstructured":"Pan Y, You Y, Sun L, Sui Q, Liu L, Yuan H et al (2021) The STING antagonist H-151 ameliorates psoriasis via suppression of STING\/NF-\u03baB-mediated inflammation. Br J Pharmacol 178(24):4907\u20134922","journal-title":"Br J Pharmacol"},{"issue":"49","key":"2450_CR282","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi2465","volume":"9","author":"W Xiang","year":"2023","unstructured":"Xiang W, Lv H, Xing F, Sun X, Ma Y, Wu L et al (2023) Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation. Sci Adv 9(49):eadi2465","journal-title":"Sci Adv"},{"key":"2450_CR283","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.2147\/JIR.S350109","volume":"15","author":"M Wang","year":"2022","unstructured":"Wang M, Pan W, Xu Y, Zhang J, Wan J, Jiang H (2022) Microglia-mediated neuroinflammation: a potential target for the treatment of cardiovascular diseases. J Inflamm Res 15:3083\u20133094","journal-title":"J Inflamm Res"},{"issue":"1","key":"2450_CR284","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-025-01144-8","volume":"32","author":"KW Kwon","year":"2025","unstructured":"Kwon KW, Choi E, Kim H, Kim HW, Choi S, Lee S et al (2025) Adjunctive beneficial effect of c-di-GMP, a STING agonist, in enhancing protective efficacy of TLR4-adjuvanted tuberculosis subunit vaccine formulations. J Biomed Sci 32(1):52","journal-title":"J Biomed Sci"},{"key":"2450_CR285","doi-asserted-by":"publisher","first-page":"103318","DOI":"10.1016\/j.redox.2024.103318","volume":"76","author":"H Rui","year":"2024","unstructured":"Rui H, Yu H, Chi K, Han Z, Zhu W, Zhang J et al (2024) ALDH2 deficiency augments atherosclerosis through the USP14-cGAS-dependent polarization of proinflammatory macrophages. Redox Biol 76:103318","journal-title":"Redox Biol"},{"issue":"1","key":"2450_CR286","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41467-023-36523-y","volume":"14","author":"JY Li","year":"2023","unstructured":"Li JY, Zhao Y, Gong S, Wang MM, Liu X, He QM et al (2023) TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models. Nat Commun 14(1):865","journal-title":"Nat Commun"},{"key":"2450_CR287","doi-asserted-by":"publisher","DOI":"10.1172\/JCI165140","author":"W Zhang","year":"2024","unstructured":"Zhang W, Li G, Zhou X, Liang H, Tong B, Wu D et al (2024) Disassembly of the TRIM56-ATR complex promotes cytoDNA\/cGAS\/STING axis-dependent intervertebral disc inflammatory degeneration. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI165140 \u00a0IF: 14.3 Q1 B1","journal-title":"J Clin Invest"},{"issue":"5","key":"2450_CR288","doi-asserted-by":"publisher","first-page":"112442","DOI":"10.1016\/j.celrep.2023.112442","volume":"42","author":"G Qian","year":"2023","unstructured":"Qian G, Zhang Y, Liu Y, Li M, Xin B, Jiang W et al (2023) Glutamylation of an HIV-1 protein inhibits the immune response by hijacking STING. Cell Rep 42(5):112442","journal-title":"Cell Rep"},{"issue":"4","key":"2450_CR289","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ni.3356","volume":"17","author":"P Xia","year":"2016","unstructured":"Xia P, Ye B, Wang S, Zhu X, Du Y, Xiong Z et al (2016) Glutamylation of the DNA sensor cGAS regulates its binding and synthase activity in antiviral immunity. Nat Immunol 17(4):369\u2013378","journal-title":"Nat Immunol"},{"issue":"3","key":"2450_CR290","doi-asserted-by":"publisher","first-page":"e2203718","DOI":"10.1002\/advs.202203718","volume":"10","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Zhou X, Du H, Cloer EW, Zhang J, Mei L et al (2023) STING suppresses mitochondrial VDAC2 to govern RCC growth independent of innate immunity. Adv Sci (Weinh) 10(3):e2203718","journal-title":"Adv Sci (Weinh)"},{"issue":"7748","key":"2450_CR291","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41586-019-1000-2","volume":"567","author":"C Zhang","year":"2019","unstructured":"Zhang C, Shang G, Gui X, Zhang X, Bai XC, Chen ZJ (2019) Structural basis of STING binding with and phosphorylation by TBK1. Nature 567(7748):394\u2013398","journal-title":"Nature"},{"key":"2450_CR292","doi-asserted-by":"publisher","DOI":"10.1016\/j.dci.2023.104712","volume":"145","author":"J Yan","year":"2023","unstructured":"Yan J, Qiao G, Yin Y, Wang E, Xiao J, Peng Y et al (2023) Black carp RNF5 inhibits STING\/IFN signaling through promoting K48-linked ubiquitination and degradation of STING. Dev Comp Immunol 145:104712","journal-title":"Dev Comp Immunol"},{"key":"2450_CR293","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jare.2022.10.014","volume":"51","author":"QB Lu","year":"2023","unstructured":"Lu QB, Ding Y, Liu Y, Wang ZC, Wu YJ, Niu KM et al (2023) Metrnl ameliorates diabetic cardiomyopathy via inactivation of cGAS\/STING signaling dependent on LKB1\/AMPK\/ULK1-mediated autophagy. J Adv Res 51:161\u2013179","journal-title":"J Adv Res"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02450-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02450-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02450-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:02:12Z","timestamp":1791748932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02450-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":293,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2450"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02450-8","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"13 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not include details, images, or videos relating to an individual person.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"235"}}